SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by Registrant |X|
Filed by a Party other than the Registrant |_|
Check the appropriate box:
|X| Preliminary Proxy Statement |X| Confidential, for Use of the Com-
mission Only (as permitted by
Rule 14a-6(e)(2))
|_| Definitive Proxy Statement
|_| Definitive Additional Materials
|_| Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12
Physician Healthcare Plan of New Jersey, Inc.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified in Its Charter)
- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|_| No fee required.
|X| Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
(1) Title of each class of securities to which transaction applies: N/A
(2) Aggregate number of securities to which transaction applies: N/A
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
is calculated and state how it was determined):
The underlying value of the transaction is the purchase price of the
assigned contracts, described herein, calculated as follows:
(1) the greater of $1,000,000 or $300x number of HMO members on date of
closing, plus (2) $10x number of HCPC members on first anniversary of closing.
On the date of this filing the Company has 6,257 HMO members and
50,000 HCPC members.
$300 X 6,257 = $1,877,100
plus $ 10 X 50,000 = $ 500,000
----------
$2,377,100
(4) Proposed maximum aggregate value of transaction: $2,377,100 (based
on data available on date of filing)
(5) Total fee paid: $475.42
|_| Fee paid previously with preliminary materials:
|_| Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement number,
or the form or schedule and the date of its filing.
(1) Amount previously paid: $_______________________________
(2) Form, Schedule or Registration Statement no: ___________
(3) Filing Party: __________________________________________
(4) Date filed: ____________________________________________
<PAGE>
[For the Letterhead of PHPNJ]
September 30, 1997
To Our Stockholders:
I am pleased to enclose information relating to the Special Meeting of
Stockholders of Physician Healthcare Plan of New Jersey, Inc. ("PHPNJ") to be
held at the Brunswick Hilton, 3 Tower Center Boulevard, East Brunswick, New
Jersey on October 30, 1997 at 7:00 p.m.
At the meeting you will be asked to consider and vote upon a proposal to
approve an agreement with Medigroup of New Jersey, Inc. (HMO Blue), which
involves the sale of PHPNJ's HMO and PPO group contracts, provider agreements
and other participation and ancillary services agreements. The transaction is
more fully described in the enclosed Proxy Statement. HMO Blue is the HMO formed
by Blue Cross/Blue Shield of New Jersey, Inc.
Your Board of Directors has approved the agreement after reviewing
several transaction proposals, and believes that it is in the best interest of
the company and our stockholders that the stockholders approve the agreement and
transaction with HMO Blue. In particular, this transaction offers members of the
PHPNJ community an opportunity to participate on several leading committees, and
up to 140 representatives of PHPNJ will serve on HMO Blue's specialty panels. In
addition, in the view of the Board of Directors, this transaction will permit
PHPNJ to preserve more cash for the benefit of the company and our stockholders.
Accordingly, the Board of Directors recommends that you vote to authorize this
transaction. Please sign and return the enclosed proxy, using the enclosed
envelope, or attend the meeting and vote in person.
Sincerely,
Joseph D. Billotti, M.D.
Chairman
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
C/O THE PACE GROUP, INC.
12160 ABRAMS ROAD, SUITE 409
DALLAS, TEXAS 75243
------------------------
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON OCTOBER 30, 1997
NOTICE IS HEREBY GIVEN that a Special Meeting of Stockholders of
Physician Healthcare Plan of New Jersey, Inc., a New Jersey corporation (the
"Company"), will be held at the Brunswick Hilton, 3 Tower Center Boulevard, East
Brunswick, New Jersey on Thursday, October 30, 1997 at 7:00 p.m., local time,
for the purpose of considering and acting upon the following:
1. Authorizing (a) the execution, delivery and performance by the
Company of a certain Agreement dated as of June 26, 1997 by and between
Medigroup of New Jersey, Inc. and the Company relating to the purchase of the
HMO and PPO operations of the Company, as such agreement may be amended to
comply with regulatory requirements (the "Agreement"), and (ii) other
instruments and documents required to be executed and delivered by the Company
as described in the Agreement, and (b) the consummation of the assignment and
transfer of certain of the Company's contracts as described in the Agreement;
and
2. Transacting such other business as properly may come before the
meeting or any adjournment thereof.
Only stockholders of record at the close of business on [September 15,
1997] will be entitled to notice of and to vote at the meeting or any
adjournments thereof. Accompanying this notice is a proxy statement and proxy
card. Whether or not you plan to attend the meeting, please indicate your choice
on the matters to be voted upon, date and sign the enclosed proxy and return it
to the Company in the enclosed postage-paid return envelope. You may revoke your
proxy at any time prior to its exercise by written notice to the Company, by
executing a proxy bearing a later date, or by attending the meeting and voting
in person after notifying the Company's Secretary in writing of the revocation
of the proxy.
You are cordially invited to attend the meeting in person.
By order of the Board of Directors
/s/ Bessie Sullivan, M.D.
Secretary
September 30, 1997
<PAGE>
PRELIMINARY COPY
----------------
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
C/O THE PACE GROUP, INC.
12160 ABRAMS ROAD, SUITE 409
DALLAS, TEXAS 75243
PROXY STATEMENT
SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON OCTOBER 30, 1997
The enclosed proxy is being solicited by and on behalf of the Board of
Directors of Physician Healthcare Plan of New Jersey, Inc., a New Jersey
corporation ("PHPNJ" or the "Company"), for a Special Meeting of Stockholders of
the Company to be held on Thursday, October 30, 1997 at 7:00 p.m., local time,
at the Brunswick Hilton, 3 Tower Center Boulevard, East Brunswick, New Jersey,
or any adjournment thereof. It is anticipated that this Proxy Statement and
accompanying proxy will be mailed to stockholders on or about September 30,
1997. Stockholders of record at the close of business on September 15, 1997 (the
"Record Date") will be entitled to notice of, and to vote at, the meeting.
The purpose of the meeting is to consider and act upon the
authorization of (a) the execution, delivery and performance by the Company of
(i) a certain Agreement dated as of June 26, 1997, by and between Medigroup of
New Jersey, Inc. and the Company relating to the purchase of the HMO and PPO
operations of the Company, as such agreement may be amended to comply with
regulatory requirements (the "Agreement"), and (ii) other instruments and
documents required to be executed and delivered by the Company as described in
the Agreement, and (b) the consummation of the assignment and transfer of
certain of the Company's contracts as described in the Agreement; and the
transaction of such other business as properly may come before the meeting or
any adjournment thereof.
On the Record Date, the Company had 4,631 shares of common stock, no
par value per share, outstanding and entitled to vote at the meeting. Each share
is entitled to one vote. Ten percent (10%) of the shares outstanding on the
Record Date represented by proxy or in person at the meeting will constitute a
quorum for the transaction of business at the meeting. An affirmative vote of a
majority of the votes cast by stockholders entitled to vote in person or by
proxy will be necessary for approval of the proposals described herein.
Abstentions are counted for the purposes of determining the presence or absence
of a quorum for the transaction of business and, with respect to votes cast in
connection with the proposals described herein, abstentions have the same effect
as a vote against a proposal. Non-votes will have no effect in determining the
presence of a quorum or the outcome of the vote. Because the Company has more
than 1,000 stockholders, the stockholders will not be
<PAGE>
entitled to dissent from the actions to be considered by the stockholders at the
meeting as provided in Section 14A:11-1 of the New Jersey Business Corporation
Act, as amended (the "NJBCA"), pursuant to the exception from the right to
dissent set forth in Section 14A:11-1(1)(b)(i) of the NJBCA.
IT IS ANTICIPATED THAT THE DIRECTORS AND OFFICERS WILL VOTE THEIR
SHARES OF COMMON STOCK IN FAVOR OF THE PROPOSALS DESCRIBED HEREIN.
The cost of soliciting proxies will be borne by the Company. The
Company may solicit proxies in person or by telephone, in addition to
solicitation by mail. All such further solicitation will be made by directors or
officers of the Company, who will not be additionally compensated. The Company
has made no arrangements for the forwarding, at the Company's expense, of
soliciting materials by brokers, nominees, fiduciaries or other custodians and
their principals, because the Company's stock ledger does not indicate that any
such parties are record holders of shares of the Company's common stock.
Shares represented by proxies that are properly executed and received
in time for the meeting will be voted in accordance with the stockholders'
specifications. In the absence of specific instructions to the contrary, proxies
received in response to this solicitation will be voted FOR the authorization of
the execution, delivery and performance by the Company of the Agreement, and
other instruments and documents required to be executed and delivered by the
Company as described therein, and the consummation of the assignment and
transfer of certain of the Company's contracts as described in the Agreement.
Should any other matter properly come before the meeting, the persons named as
proxies will, unless otherwise specified in the proxy, vote upon such matters in
their discretion. A proxy may be revoked at any time prior to its exercise by
written notice to the Company, by executing a proxy bearing a later date, or by
attending the meeting and voting in person after notifying the Company's
Secretary in writing of the revocation of the proxy. Notwithstanding the
foregoing, in the event that the substance of the transaction contemplated by
the Agreement or the amount of the purchase price described therein is
materially modified as a result of requirements imposed by applicable regulatory
authorities, the Company would consider whether supplemental proxy materials
must be delivered to stockholders and, if such regulatory requirements are
imposed after the date of the Special Meeting of Stockholders, whether
subsequent action by the stockholders is necessary.
2
<PAGE>
TABLE OF CONTENTS
PAGE
Summary 4
Proposal to Approve Agreement 7
Relating to the Purchase of the HMO and PPO Operations
of the Company and Related Matters
Business 23
Interest of Certain Persons in Matters to be Acted Upon 30
Securities Ownership of Certain Beneficial Owners and 30
Management
Financial Statements 31
Management's Plan of Operation 54
Market Price and Dividend Information 56
Independent Public Accountants 57
Other Matters 57
Available Information 57
Exhibit A
- ---------
Form of Agreement between Physician Healthcare Plan
of New Jersey, Inc., and Medigroup of New Jersey, Inc.
Exhibit B
- ---------
Opinion of Shattuck Hammond Partners Inc.
3
<PAGE>
SUMMARY
The following Summary should be read in conjunction with the more detailed
information included elsewhere in this Proxy Statement and the exhibits hereto.
The discussion in this Proxy Statement contains certain forward-looking
statements that involve risks and uncertainties, such as statements of the
Company's plans, objectives, expectations and intentions. The statements should
not be regarded as a representation by the Company that the expectations or
plans of the Company will be achieved. Actual results or events could differ
materially from those discussed herein. Factors that could cause or contribute
to such differences include but are not limited to the effect of requirements
imposed by regulatory agencies in connection with the review and approval of the
proposed transaction described herein, the amount of claims payable by the
Company in respect of services provided under its plans, the ability of the
Company to increase or at least maintain levels of member enrollment in the
Company's plans, the ability of the Company's new management company to manage
the Company, the ability of the Company to accurately forecast expenditures, and
conditions in the Company's marketplace.
The Company
Physician Healthcare Plan of New Jersey, Inc., incorporated in 1994, is
a physician-owned and directed health maintenance organization ("HMO") which
operates in the State of New Jersey pursuant to a Certificate of Authority
issued by the New Jersey Department of Banking and Insurance and Department of
Health and Senior Services. The Company has developed and markets HMO, preferred
provider organization ("PPO") and point-of-service ("POS") products, and has
devoted substantial efforts to developing and credentialing its health care
delivery network. Since inception, the Company has engaged a management company
to provide substantially all management and administrative services, including,
but not limited to, financial services, member and provider support services,
provider credentialing, and claims processing. Until July 1997, the Company was
managed by Medical Group Management, Inc., a subsidiary of New Jersey State
Medical Underwriters, Inc., which in turn is a subsidiary of the Medical Society
of New Jersey. Currently, the Company is managed by Medigroup of New Jersey,
Inc. (the "Purchaser").
Additional information about the Company appears herein under the
captions "BUSINESS,"and "MANAGEMENT'S PLAN OF OPERATIONS," and in the Company's
Financial Statements and Notes thereto.
Summary of the Proposed Transaction
The Company and the Purchaser have entered into the Agreement as of
June 26, 1997, the form of which is attached hereto as Exhibit A. The Agreement
provides for the acquisition by the Purchaser of group contracts and certain
provider agreements, constituting the Company's HMO and PPO operations, for a
cash purchase price at closing equal to the greater of $1,000,000 or $300 per
each HMO member enrolled in the Company's plans at the date of closing of the
transaction.
4
<PAGE>
In addition, on the first anniversary of the closing, the Purchaser will pay the
Company an amount in cash equal to $10 for each Health Care Payer Coalition
("HCPC") member to whom the services of the Purchaser's network of providers are
available on the first anniversary of the closing. No assurance can be given
regarding the number of HMO members at the date of closing or the number of HCPC
members to whom services of the Purchaser's provider network will be available
on the first anniversary of the closing. Therefore, no assurance can be given
that the Company will receive more than the minimum price of $1,000,000 for this
transaction.
The Purchaser will assume the Company's obligations under the acquired
contracts from the date of closing of the transaction. The Company will remain
liable for any obligations arising under the contracts before the date of
closing. The Company also will be permitted to select certain physicians who
will be appointed to various committees, panels and board of the Purchaser or
its affiliates. The Company has agreed that it will not engage in the managed
care business for a period of one year after closing. The Agreement is subject
to approval by the New Jersey Department of Banking and Insurance and the New
Jersey Department of Health and Senior Services. As of the date hereof, such
approvals have not yet been obtained.
If the Agreement is approved by the stockholders of the Company and the
applicable state regulators, the Company will surrender its Certificate of
Authority to the Department of Banking and Insurance at such time as the
Department is satisfied that all obligations of the Company arising prior to
closing have been paid or provided for. Management expects that the Company will
then voluntarily liquidate after the surrender of the Certificate, at which time
amounts remaining, if any, after satisfaction of the Company's liabilities would
be distributed to stockholders. Liquidation will require additional stockholder
approval. At this time, the Company is unable to estimate when the Certificate
will be surrendered, when a liquidation would occur, or what amount, if any,
would be available for distribution to stockholders upon liquidation of the
Company.
The Company has entered into a Management Services Agreement with the
Purchaser, effective July 1, 1997, pursuant to which the Purchaser is providing
substantially all the management and administrative services necessary for the
operation of the Company's business. The management fee payable under the
Management Services Agreement currently is $15 per member per month. The fee
increases in the event that stockholder or regulatory approval is not obtained
by a certain time. See "PROPOSAL TO APPROVE AGREEMENT RELATING TO THE PURCHASE
OF THE HMO AND PPO OPERATIONS OF THE COMPANY AND RELATED MATTERS - Management
Arrangements with the Purchaser." The Management Services Agreement is not
subject to stockholder approval but must be approved by the Department of
Banking and Insurance and Department of Health and Senior Services. The
Department of Banking and Insurance has approved the Management Services
Agreement subject to the concurrence of the Department of Health and Senior
Services, which has not acted as of the date hereof.
5
<PAGE>
Since operations commenced in 1995, the Company has experienced
significant competitive pressures in its marketplace, resulting in the inability
to become profitable. In the Spring of 1997, the Board of Directors charged the
Board's Due Diligence Committee with identifying strategic options and
recommending a course of action that would be most beneficial to the Company and
its stockholders. After evaluating proposed transactions or alliances with four
companies, the Board of Directors determined that the terms and conditions of
the proposed transaction with the Purchaser were expedient and in the best
interest of the Company and its stockholders. The Board of Directors has
received an opinion of Shattuck Hammond Partners Inc., an investment banking
firm, that the consideration to be paid by the Purchaser is fair from a
financial point of view to the stockholders of the Company. The opinion is
attached hereto as Exhibit B. See "PROPOSAL TO APPROVE AGREEMENT RELATING TO THE
PURCHASE OF THE HMO AND PPO OPERATIONS OF THE COMPANY AND RELATED MATTERS" for a
more detailed discussion of the terms of the Agreement and related matters.
Advantages and Disadvantages of the Transaction
In the view of the Board of Directors of the Company, the primary
advantages of the proposed transaction with the Purchaser are (1) the
preservation of cash, resulting from the application of the cash proceeds of the
transaction to the payment of claims liabilities, the assumption by the
Purchaser of claims obligations post-closing and the payment of lower management
fees, potentially resulting in more cash for distribution to stockholders upon
the liquidation of the Company, (2) the opportunity for physicians to continue
to be involved in the direction of managed care in New Jersey through
participation on the committees, panels and board described in the Agreement,
and (3) the continuation of subscriber and provider relationships because of the
assumption by the Purchaser of certain existing agreements. The Board of
Directors believes that the primary disadvantage of the proposed transaction
with the Purchaser is the necessity of remaining in existence for a period of
time after closing in order to pay claims incurred but not reported prior to
closing, rather than quickly winding down and making a distribution, if
available, to stockholders.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE PROPOSAL DESCRIBED IN THIS
PROXY STATEMENT.
6
<PAGE>
PROPOSAL TO APPROVE AGREEMENT RELATING TO THE PURCHASE OF THE
HMO AND PPO OPERATIONS OF THE COMPANY AND RELATED MATTERS
General
Since 1995, the Company has been engaged in the business of operating a
physician-owned and directed health maintenance organization in the State of New
Jersey (the "Plan"). As of June 26, 1997, the Company entered into the Agreement
with Medigroup of New Jersey, Inc., as purchaser, pursuant to which the
Purchaser will acquire the HMO and PPO operations of the Company. Medigroup,
Inc. ("Medigroup") and Blue Cross and Blue Shield of New Jersey, Inc. ("BCBSNJ")
have joined in the Agreement for certain limited purposes. The Purchaser
operates a health maintenance organization in the State of New Jersey known as
"HMO Blue." The Purchaser is a wholly owned subsidiary of Medigroup, which in
turn is a wholly owned subsidiary of BCBSNJ. The form of the Agreement is
attached hereto as Exhibit A.
The parties anticipate that the transaction contemplated by the
Agreement will close on or before December 31, 1997, if all approvals can be
obtained and other conditions satisfied by that date.
The Company also has entered into a Management Services Agreement with
the Purchaser, dated as of June 26, 1997 (the "Management Services Agreement"),
pursuant to which the Purchaser began providing management services to the
Company effective July 1, 1997. This agreement does not require stockholder
approval. See "Management Arrangements with the Purchaser" for a description of
the Management Services Agreement.
Summary of Terms of the Agreement Regarding the Purchase of the HMO and PPO
Operations of the Company
The following is a summary of the Agreement, which is qualified in its
entirety by the terms of the Agreement attached as Exhibit A to this Proxy
Statement.
Transfer of Contracts
---------------------
Pursuant to the terms of the Agreement, the Purchaser will acquire and
assume from the Company all right, title and interest of the Company in the
group contracts and provider agreements described below (the "Contracts"). The
Purchaser also will assume from the Company all of the Company's duties and
obligations arising under the Contracts after the date of closing of the
transaction contemplated by the Agreement (the "Closing Date").
The Contracts to be transferred to the Purchaser are as follows:
o All HMO and PPO group account contracts
7
<PAGE>
o Provider participation agreements with primary care
physicians, provided however, that if a physician fails to
meet applicable credentialing requirements of Medigroup, such
agreement will be excluded
o Provider participation agreements with specialty care
physicians, provided, however that if a physician fails to
meet applicable credentialing requirements of Medigroup, such
agreement will be excluded
o PPO agreements, ancillary provider services agreements and
hospital participation agreements
Notwithstanding the transfer of the Contracts, the Company will retain
all cash on hand, cash equivalents, investments and bank deposits; all accounts,
premiums or other amounts due to the Company for the period up to and including
the Closing Date; tax refunds, tax, insurance and other claims or rights to
recover and similar benefits of the Company's business and any prepaid items
with respect to the Company's business prior to the Closing Date; and all other
assets of the Company except for the Contracts. The Purchaser is not required to
assume or perform any liabilities or obligations of the Company relating to any
stockholder of the Company or the operation of the Company's business prior to
the Closing Date.
Purchase Price; Expenses; Deposit
---------------------------------
The Purchaser will pay the Company for the Contracts an amount equal to
the sum of (a) the greater of $1,000,000 or $300 per health maintenance
organization member certified by the Purchaser, to be enrolled in the Plan (the
"Certified Number") as of the Closing Date (the "Closing Installment"), (b) any
interest on the Deposit (hereinafter defined) and (c) $10 for each eligible
Health Care Payers Coalition ("HCPC") life to whom the services of the
Purchaser's provider network are available on the first anniversary of the
Closing Date (the "Subsequent Installment"). Although the Company had 6,257 HMO
members at September 1, 1997 and the services of the Company's provider network
were available to 50,000 HCPC members as of that date, no assurance can be given
of the number of HMO members as of the Closing Date or the number of HCPC
members to whom the services of the Purchaser's provider network will be
available as of the first anniversary of the Closing Date. Therefore, there can
be no assurance that the Company will receive more than $1,000,000 for the
Contracts.
The Closing Installment and interest on the Deposit will be paid to the
Company in immediately available funds on the Closing Date and the Subsequent
Installment will be payable to the Company in immediately available funds on the
first anniversary of the Closing Date. Within 30 days after the Closing Date,
the Company at its sole expense may verify the Certified Number by independent
audit. If the number of members determined by such audit to be enrolled in the
Plan is lower than the Certified Number, the Company will rebate to the
Purchaser an amount equal to $300 times such difference; provided, however that
any such rebate will not reduce the Closing Installment below $1,000,000. If the
number of members determined by such audit to be enrolled in the Plan is
8
<PAGE>
higher than the Certified Number, then the Purchaser will pay the Company an
amount equal to $300 times such difference.
Each party will pay its own costs and expenses incurred in connection
with the Agreement, the Management Services Agreement and the transactions
contemplated therein. The Purchaser will pay any excise, sales, value added,
use, registration, stamp, transfer and similar taxes or charges (other than
income taxes due and payable by the Company.)
The Purchaser has paid the Company a deposit of $500,000, which is
being held by Mellon Bank, N.A. as escrow agent (the "Deposit"). If the
stockholders of the Company approve the Agreement and if the required regulatory
approvals, described below, are obtained, the Deposit and interest thereon will
be disbursed to the Company and the Deposit will be credited against the
purchase price. If the stockholders disapprove the transaction or if the
regulatory approvals are not obtained, then the Deposit and all interest thereon
will be returned to the Purchaser. If the stockholders have not approved the
Agreement by June 26, 1998 and the Purchaser exercises its termination rights in
such event as provided in the Agreement, $250,000 of the Deposit will be
disbursed to the Purchaser and $250,000 plus all interest on the Deposit will be
disbursed to the Company.
Post-Closing Treatment of Premiums and Claims
---------------------------------------------
From and after the Closing Date, if the Purchaser receives premiums
payable under any of the Contracts for the period prior to the Closing Date, the
Purchaser will promptly pay them over to the Company on a weekly basis. When the
Purchaser properly pays any claims incurred prior to the Closing Date, the
Company will reimburse the Purchaser within one business day after the Company's
receipt of the Purchaser's invoice for such payments. Such invoices will be
submitted no more frequently than once weekly. All reimbursements by the Company
will be subject to subsequent audit and verification, and the Purchaser will
provide the Company with reasonable access to its books and records relating to
the payment of such claims.
Appointments to Boards and Committees
-------------------------------------
In connection with the closing of the transaction contemplated by the
Agreement, the Company will select two physicians to be appointed by BCBSNJ to
BCBSNJ's Medical Policy Committee and one physician to be appointed to BCBSNJ's
Professional Advisory Committee. The Company will select two physicians to be
appointed by the Purchaser to the Purchaser's Quality Improvement Committee and
two physicians to be appointed to such committee's subcommittees on Clinical
Issues, Credentialing and Grievance/Appeals. The Company will select two
physicians meeting the Purchaser's applicable credentialing requirements for
appointment by the Purchaser to its Panel of Independent Medical Examiners for
each specialty represented on such panel. The Company will be entitled to
appoint physicians to each of the committees or panels, or their successors, for
at least five years. In addition, the Company will present a slate of at least
three
9
<PAGE>
physicians from which one physician will be appointed by Medigroup's stockholder
to the Board of Directors of Medigroup for a minimum term of three years.
Proposal for Princeton Product
------------------------------
Also in connection with the closing, the Purchaser must provide a
proposal regarding an HMO product to be offered by Princeton Medical Management,
LLC ("PMM"). PMM is a joint venture of the Company and the Medical Center at
Princeton Physician Hospital Organization, organized in 1996 to market and
manage a proposed product to be known as "Princeton Preferred Health Plan." The
Purchaser and PMM representatives currently are discussing proposals for a
possible product.
Non-Competition Provisions
--------------------------
The Company has agreed that neither it nor any entity of which it is a
majority owner will, directly or indirectly, engage in the business of providing
or arranging for the provision of managed health care insurance (including HMO,
PPO, POS and ASO arrangements) in the State of New Jersey for a period of one
year after the Closing Date. In addition, for a period of five years following
the surrender of the Company's Certificate of Authority to the State of New
Jersey, the Company has agreed that it and its affiliates will not use any name,
trade name, trademark, brand name or service mark, including without limitation,
"Physician Healthcare Plan of New Jersey," that is confusingly similar to those
used by the Company as of the Closing Date.
Indemnification by the Company
------------------------------
The Company has agreed to indemnify and hold harmless the Purchaser and
its officers, directors, employees, agents, successors and assigns from and
against any and all liabilities, losses and expenses actually incurred by such
indemnified parties as a result of (i) the breach by the Company of any
representation, warranty, covenant or agreement contained in the Agreement or
any other document delivered on the Closing Date (except to the extent such
breach was caused by the Purchaser as manager of the Company's operations), and
(ii) the failure of the Company to pay or otherwise discharge any liability or
obligation incurred by it in connection with the Contracts or the operations of
the Company prior to the Closing Date (except to the extent such failure was
caused by the Purchaser as manager of the Company's operations). The Agreement
provides that the aggregate amount for which the Company may be liable under the
indemnification provisions of the Agreement will not exceed the greater of
$1,000,000 or $300 times the Certified Number as such number may be adjusted
after audit as provided in the Agreement.
Indemnification by the Purchaser
--------------------------------
The Purchaser has agreed to indemnify and hold harmless the Company and
its officers, directors, employees, agents, independent contractors, successors
and assigns from and against any and all liabilities, losses and expenses
actually incurred by such indemnified parties as a result of (i)
10
<PAGE>
the breach by any of the Purchaser, Medigroup and BCBSNJ of any representation,
warranty, covenant or agreement contained in the Agreement or any other document
delivered on the Closing Date, and (ii) the failure of any of the Purchaser,
Medigroup and BCBSNJ to pay or otherwise discharge any liability or obligation
incurred by such party in connection with the Contracts or the operations of the
Company from and after the Closing Date, except for liabilities expressly not
assumed by the Purchaser as provided in the Agreement.
Termination
-----------
The Agreement may be terminated at any time prior to the Closing Date
(i) by the written consent of the Company and the Purchaser, (ii) by either
party if it becomes clear that a condition precedent to such party's obligations
under the Agreement can not be satisfied and the other party cannot cure the
deficiency, (iii) by the Company if the Purchaser defaults under the Management
Services Agreement (in which event, the entire Deposit and interest thereon
shall be disbursed to the Company), (iv) by the Purchaser if the Company
defaults under the Management Services Agreement (in which event, the entire
Deposit and all interest thereon will be disbursed to the Purchaser), (v) by the
Purchaser, upon written notice, if twelve or more months have elapsed since the
date of the Agreement and the stockholders of the Company have not approved the
Agreement prior to such notice (in which event, $250,000 of the Deposit will be
disbursed to the Purchaser and the remainder of the Deposit and all interest
thereon will be disbursed to the Company), (vi) by the Purchaser, upon 90 days
written notice, if twelve or more months have elapsed since the date of the
Agreement and the stockholders of the Company have approved the Agreement prior
to such notice but the regulatory approvals have not yet been secured (in which
event the entire Deposit and all interest thereon shall be disbursed to the
Company); provided, however, that the Purchaser and the Company will utilize
best efforts to secure such approvals during the 90 day period between the
Purchaser's notice and date of termination of the Agreement, and (vii) by the
Company, upon written notice, if twelve months or more have elapsed since the
date of the Agreement (in which event the entire Deposit and all interest
thereon shall be disbursed to the Purchaser).
Other Representations, Warranties and Covenants
-----------------------------------------------
Each party has made various representations to the other, among other
things, with respect to the organization and qualification of such party and its
corporate power and authority to conduct its business; the validity of the
Agreement; the absence of conflicts with other documents arising from the
execution, delivery and performance of the Agreement; and the accuracy of
disclosures made by such party.
Pending the Closing Date, the parties have agreed, among other things,
that the Purchaser as manager shall not, and the Company shall not or cause the
Purchaser as manager to, conduct the Company's business other than in the
ordinary course, except that the Company may choose not to engage in active
selling of its product line. The parties have also agreed to other limitations
on the conduct of the Company's business which are customary in connection with
the sale of substantially all of the assets of a company. The parties have
agreed to keep each other informed of significant
11
<PAGE>
decisions regarding the Company's business and to take reasonable steps to
retain the Company's existing relationships with providers, subscribers and
third party payors, and to cooperate fully with one another to effect the
transfer of the Contracts, and to obtain the required regulatory approvals. The
Company also has agreed to explore with the Purchaser a mutually acceptable form
of endorsement by the Company of the Purchaser for the period of time after the
Closing Date that the Company maintains its Certificate of Authority in the
State of New Jersey.
Each party has also agreed to maintain the confidentiality, except as
required by law, of certain non-public information obtained by it from the other
or the other's agents or representatives.
Reasons for Engaging in the Transaction
From the time that operations commenced in 1995, the Company has
experienced significant competitive pressures in its marketplace, resulting in
the inability to become profitable. By April 1996, the Company's leadership
recognized that changing market conditions, coupled with attendant network,
pricing and product issues, were negatively impacting the Company's operations.
The Company attempted to implement new strategies to improve operating results.
A more detailed discussion of the development of the Company's business and the
components of the Company's strategies appears below under the caption
"BUSINESS". Early in 1997, the Board of the Directors of the Company determined
that it had become difficult, if not impossible, for the Company to gain a
viable position in the marketplace as a "stand alone" health maintenance
organization. The primary barrier to becoming a successful 100% physician owned
and guided managed health care company was the lack of capital. Because the
financial resources of the Company were, and remain, extremely limited in
comparison to the much larger HMO's in the Company's marketplace, the Board of
Directors determined that the Company could not afford to engage in a premium
war with larger organizations in order to gain market share and contracts with
large groups of members.
The Board of Directors established a Due Diligence Committee and
appointed the following members: Raj Prasad Gupta, M.D., Chairperson, Joseph D.
Billotti, M.D., William Brennan, D.O., Raymond P. Kenny, M.D., Emmons G. Paine,
M.D., Barry Prystowsky, M.D., and Bessie Sullivan, M.D. The Board of Directors
charged the Board's Due Diligence Committee with identifying strategic options
and recommending a course of action that would be most beneficial to the Company
and its stockholders. The Committee sought to identify a partner with financial
strength and the ability to offer continued physician involvement in managed
care management. In March 1997, the Committee engaged Shattuck Hammond Partners
Inc. ("Shattuck Hammond") to assist it in soliciting, evaluating and negotiating
the proposals. During the Spring of 1997, the Committee solicited and considered
a variety of proposed alliances with four companies.
The Committee reviewed proposals from and attended presentations by
National Health Plan Plus, Inc., a development stage HMO, which proposed a share
exchange for an undetermined valuation or a cash payment per share of book value
at the time of the closing; NextStage Healthcare, Inc., an HMO management
company, which proposed assuming the management of the Company without making a
capital infusion; Atlantic Health System, a group of hospitals, and New Jersey
12
<PAGE>
Health Resources, Inc., a practice management company, which proposed to acquire
up to a 50% interest in the Company for a combination of cash and notes based
upon an undetermined valuation; and Blue Cross and Blue Shield of New Jersey,
the leading indemnity insurer in the State of New Jersey which also operates,
through a subsidiary, the health maintenance organization known as "HMO Blue",
and which proposed the transaction described in the Agreement.
The Committee believed that the BCBSNJ proposal represented the best
combination of financial strength, opportunity for continued physician
involvement in managed care management, and continued service to members and
providers because of HMO Blue's experience in marketing and operating an HMO in
the New Jersey market. In addition, the Committee concluded that a sale of the
Company's contracts for cash and the engagement of the Purchaser to provide
management services to the Company would permit the Company to reduce the
magnitude of financial losses currently being incurred by the Company as a
result of the application of the cash proceeds of the sale of the Contracts to
the payment of pre-closing liabilities, the transfer of post-closing claims
obligations to the Purchaser and the payment to the Purchaser of a management
fee lower than that being paid by the Company to its former management company.
The Committee believed that the reduction of financial losses would preserve
more cash for potential distribution to stockholders. Based upon the foregoing
considerations, among others, the Committee believed that the proposed
transaction with the Purchaser would be in the best interest of the Company and
its stockholders.
Therefore, the Committee recommended to the Board of Directors that
the Board consider the proposed transaction with the Purchaser. The Board
concurred with the Committee's recommendation, based on the foregoing
considerations and terms negotiated among senior management of all parties and
their respective counsel, and representatives of Shattuck Hammond on behalf of
the Company. The Board approved the execution of a letter of intent on June 11,
1997, and on June 26, 1997 the Board approved the execution of the Agreement and
the submission of the Agreement and the transaction contemplated therein to the
stockholders for approval.
In the view of the Board of Directors, the primary advantages of the
proposed transaction with the Purchaser are (1) the preservation of cash,
resulting from the application of the cash proceeds of the transaction to the
payment of claims liabilities, the assumption by the Purchaser of claims
obligations post-closing, and the payment of lower management fees, potentially
resulting in more cash for distribution to stockholders upon the liquidation of
the Company (2) the opportunity for physicians to continue to be involved in the
direction of managed care in New Jersey through participation on the committees,
panel and board described in the Agreement, and (3) the continuation of
subscriber and provider relationships because of the Purchaser's assumption of
certain existing agreements. In addition, the Board of Directors believes that
BCBSNJ and the Purchaser would be partners acceptable to applicable regulatory
authorities thereby permitting the transaction to occur as expeditiously as
possible. The Board of Directors believes that the sooner the transaction
contemplated by the Agreement is consummated, the better opportunity the Company
will have to reduce the magnitude of the financial losses currently being
incurred by the Company. In the view of the Board of Directors, the primary
disadvantage of the proposed transaction with the Purchaser is the necessity of
remaining in existence for a period of time after closing in order to pay claims
13
<PAGE>
incurred but not reported prior to the Closing Date, rather than quickly winding
down and making a distribution, if available, to the stockholders. The
non-competition covenant that the Company has agreed to does not, in the opinion
of the Board of Directors, constitute a material disadvantage to the Company
resulting from the Agreement, because the Company has had significant
difficulties competing in its marketplace and would be unlikely to re-enter the
managed health care business in a meaningful way during the one year period
contemplated by the non-competition covenant.
Recent Developments
On August 20, 1997, the Company received an unsolicited acquisition
proposal from QualCare, Inc., a preferred provider organization located in New
Jersey ("QualCare"). The proposal was subject to QualCare conducting a due
diligence investigation of the financial, operational, personnel, legal and
regulatory records of PHPNJ. QualCare proposed a merger whereby each share of
PHPNJ common stock would be exchanged for 10.5 shares of QualCare common stock,
resulting in PHPNJ shareholders collectively owning approximately 13% of
QualCare. Alternatively, QualCare proposed a reverse merger whereby QualCare
shareholders would own approximately 86% of PHPNJ. QualCare deemed each share of
PHPNJ to be worth $693 for purposes of its proposal. QualCare proposed to reduce
the exchange ratio on a dollar for dollar basis to the extent that PHPNJ's
liquid assets at closing were not sufficient to cover all liabilities including
claims incurred but not reported. QualCare also proposed to provide management
services for PHPNJ pending the closing of the merger. After consideration of the
proposal at a meeting on September 11, 1997, PHPNJ's board of directors
determined that further pursuing a transaction with QualCare would not be in the
best interest of PHPNJ and its stockholders. This determination was based, in
part, on the illiquidity of the consideration offered by QualCare, concerns
about QualCare's lack of experience in HMO management, and, significantly, the
likely adverse consequences to PHPNJ and its shareholders if PHPNJ abandoned the
proposed transaction with the Purchaser and attempted to negotiate and close a
transaction with QualCare. Such consequences would include the (i) termination
of the Management Services Agreement with the Purchaser and the increased costs
associated with the second management transition in one year, (ii) the increased
transaction costs for PHPNJ associated with negotiating a second substantial
transaction, and (iii) the possibility that PHPNJ would not have the capital to
cover operating losses during the period of time that would be required to
negotiate, obtain regulatory approval for, and close a transaction with
QualCare.
Potential Consequences of a Negative Vote
In the event that the proposal set forth in this Proxy Statement is not
approved by the stockholders, or if required regulatory approvals are not
obtained, the Company will attempt, to the extent the Company's financial
resources permit, to seek alternative proposals for the transfer of its
operations or other alliances or arrangements with other entities. However, if
an alternative arrangement could not be implemented quickly, the Company would
seek to voluntarily liquidate and assets remaining, if any, after satisfaction
of the Company's liabilities would be distributed to stockholders. In this
event, amounts distributed in respect of an outstanding share of the Company's
common stock would likely be substantially lower than the purchase price paid by
a stockholder for such share.
Even if the Company were able to initiate alternative arrangements
quickly, a negative vote on the proposal presented in this Proxy Statement would
have a significant adverse effect upon the Company. First, the Management
Services Agreement would terminate, and the Company would have to engage a new
manager, resulting in a significant disruption of the operations of the Company.
No assurance can be given that the Company will be able to identify and engage a
new manager quickly or to engage a manager on terms at least as favorable as
those offered by the Purchaser. Second, the Company would likely experience a
more rapid depletion of cash reserves and resulting increase in losses as a
result of (1) delays and increased costs of operations if a manager cannot be
engaged quickly on terms at least as favorable as those offered by the Purchaser
and (2) the unavailability of additional cash proceeds for the payment of claims
liabilities. A reduction of cash reserves and increase in financial losses would
reduce the amount available, if any, for distribution to stockholders upon the
liquidation of the Company, and increase the likelihood of the loss of a
stockholder's entire investment.
Opinion of Shattuck Hammond Partners Inc.
The Company's Board of Directors retained Shattuck Hammond pursuant to
a supplemental engagement letter executed on July 30, 1997 to provide an opinion
as to the fairness, from a financial point of view, of the Transaction to the
stockholders of PHPNJ, as of June 26, 1997. The full text of the written opinion
of Shattuck Hammond, which sets forth the assumptions made, procedures followed,
matters considered, limitations on and the scope of the review by Shattuck
Hammond in rendering its opinion is attached as Exhibit B to this Proxy
Statement. Terms capitalized in the summary which are not otherwise defined in
this Proxy Statement, are defined in such opinion. The summary of the opinion of
Shattuck Hammond set forth in this Proxy Statement is qualified in its
14
<PAGE>
entirety by reference to the full text of such opinion. PHPNJ stockholders are
urged to read Shattuck Hammond's opinion in its entirety. The opinion of
Shattuck Hammond does not constitute a recommendation as to any action the PHPNJ
Board should take or should have taken in connection with the Transaction. The
opinion of Shattuck Hammond is directed only to the fairness, from a financial
point of view, of the Transaction to the stockholders of PHPNJ and does not
constitute a recommendation to any PHPNJ stockholder as to how such stockholder
should vote at the Special Meeting of Stockholders. Shattuck Hammond has
expressed no opinion as to the structure, term or effect of any other aspect of'
the Transaction, including, without limitation, the tax consequences of the
Transaction to PHPNJ or any stockholder of PHPNJ.
In connection with its written opinion, Shattuck Hammond (i) reviewed
certain publicly available business and historical financial information
relating to PHPNJ; (ii) reviewed certain financial information and other data
provided to it by PHPNJ that is not publicly available relating to the business
and prospects of PHPNJ; (iii) discussed the business, operations and prospects
of PHPNJ with employees and representatives of Medical Group Management, Inc.
("MGM" or the "Designated Managers" ), the company which provided administrative
and management services to PHPNJ prior to the Purchaser, under a contract
between PHPNJ and MGM (the "MGM Contract"); (iv) reviewed the Agreement and the
Management Services Agreement entered into as of June 26, 1997 between PHPNJ and
the Purchaser and certain other agreements; (v) reviewed publicly available
financial and stock market data with respect to publicly traded companies it
considered relevant; (vi) reviewed information regarding acquisitions of
companies it considered relevant; and (vii) conducted such other studies,
analyses, investigations and inquiries, and considered such other information as
it deemed relevant.
In rendering its opinion, Shattuck Hammond assumed and relied upon the
accuracy and completeness of all information supplied or otherwise made
available to it by PHPNJ or obtained by Shattuck Hammond from other sources, and
relied upon the assurances of PHPNJ and the Designated Managers that they were
unaware of any information or facts that would make the information provided to
Shattuck Hammond incomplete or misleading. Shattuck Hammond also assumed that
the financial statements of PHPNJ presented fairly the financial position of the
Company and that retained liabilities were adequately provided for. Shattuck
Hammond did not independently verify such information, undertake an independent
appraisal of the assets or liabilities (contingent or otherwise) of PHPNJ, nor
was Shattuck Hammond furnished with any such appraisals. In addition, Shattuck
Hammond assumed that the Transaction will be consummated as provided in the
Agreement by December 31, 1997, that the Management Services Agreement took
effect on July 1, 1997, and that the Purchaser provides administrative and
management services to PHPNJ consistent with the terms of the Management
Services Agreement. (The date on which the assignment and sale of the contracts
actually is completed is referred to below as the "Closing Date" which may or
may not be December 31, 1997.)
Shattuck Hammond's opinion was necessarily based upon market, economic
and other conditions that existed and could be evaluated as of June 26, 1997 and
on information relevant to expressing an opinion as to the fairness of the
Transaction as of June 26, 1997 available to Shattuck
15
<PAGE>
Hammond as of the date of its opinion. Shattuck Hammond has disclaimed any
undertaking or obligations to advise any person of any change in any fact or
matter affecting the opinion expressed herein which may come or be brought to
its attention after the date thereof. Shattuck Hammond noted that PHPNJ does not
prepare financial forecasts and therefore did not provide any estimates of
future performance for Shattuck Hammond's consideration. No other limitations
were imposed upon Shattuck Hammond with respect to the investigations to be made
or procedures to be followed by it in rending its opinion.
The following paragraphs summarize the most significant quantitative
and qualitative analyses performed by Shattuck Hammond in arriving at its
opinion presented to PHPNJ's Board and does not purport to be a complete
description of the analyses prepared by Shattuck Hammond. The information
presented below is based upon the financial condition of PHPNJ as of a date or
dates before delivery of Shattuck Hammond's opinion and upon stock price
information of selected comparable public companies through the close of the
market on June 26, 1997.
Historical Financial Analysis. Shattuck Hammond noted that PHPNJ has
been unprofitable since its inception. For the quarter ended March 31, 1997,
PHPNJ had a net loss, before investment income, of $1,419,792. and a net loss,
after inclusion of investment income, of $1,215,241 compared to the prior year's
results of net losses of $2,605,293 and $2,478,016 respectively. As of March 31,
1997, the accumulated deficit was $15,831,458. For the latest fiscal year ended
December 31, 1996, PHPNJ had a net loss, before investment income, of
$8,451,636, and a net loss, after inclusion of investment income, of $7,809,767
compared to net losses of $5,375,854 and $4,666,112, respectively, for the
fiscal year ended December 31, 1995. The accumulated deficit as of December 31,
1996 was $14,616,217.
Selected Public Company Analysis. Shattuck Hammond analyzed the public
market valuations as of June 26, 1997 of eight managed care companies considered
by Shattuck Hammond to be reasonably comparable to PHPNJ even though their
membership and revenues were substantially larger, and their product offerings
more diverse than those of PHPNJ. Such companies had HMO enrollment of one
million or less and operations concentrated in one state or a narrow geographic
region of the United States. The companies analyzed were Mid Atlantic Medical
Services, Inc., The Wellcare Management Group, Inc., Sierra Health Services,
Inc., Physicians Health Services, Inc., Health Power Inc., Physician Corporation
of America, Right Choice Managed Care, Inc., and United Wisconsin Services, Inc.
Business Enterprise Values (" BEV"), (calculated for the public companies as
market value of equity based on the number of fully diluted shares outstanding
and closing share prices on June 26, 1997, plus, as of March 31, 1997 (the
latest quarter end), long term debt, less working capital and long term
investments) were then compared to various financial and membership measures
(stated on an adjusted full risk commercial member equivalent basis) for the
latest fiscal quarter end available. Since PHPNJ does not generate positive
earnings before interest, taxes, depreciation, and amortization ("EBITDA") or
positive net income, BEV multiples of those financial measures were irrelevant.
Average multiples were calculated for the peer group of public companies listed
above and discounted to reflect, inter alia, the illiquidity of an investment in
PHPNJ, and its minute size compared to the peer group companies, (many of which
have membership
16
<PAGE>
levels 100 or more times the size of PHPNJ). The calculated averages excluded
Sierra Health Services (whose multiples were highly divergent from the peer
group). The adjusted average revenue multiple was 0.4 x latest twelve months
revenues and the adjusted average price per member was $619. These adjusted
average multiples were applied to PHPNJ's latest twelve months' revenue and
membership levels as of the latest quarter end (March 31, 1997) to provide one
estimate of the value of PHPNJ's non-cash operating assets. Such calculations
provided a BEV reference range of approximately $0.7-2.0 million.
Selected Merger and Acquisition Transactions Analysis. Shattuck Hammond
performed an analysis of purchase prices and multiples paid or proposed to be
paid in 12 managed care transactions announced or completed since the first
quarter of 1993, which it considered relevant to an analysis of PHPNJ, and for
which relevant transaction information was available. The transactions analyzed
were: TakeCare, Inc.'s acquisition of Comprecare, Inc., Healthsource, Inc.'s
acquisition of Healthsource South Carolina, Inc., Healthsource, Inc.'s
acquisition of Healthsource Maine, Inc., Healthsource, Inc.'s acquisition of
Healthsource North Carolina, Inc., Coventry Corporation's acquisition of
Southern Health Management Corporation, Health Systems International, Inc.'s
acquisition of M.D. Enterprises of Connecticut, Inc., Health Systems
International, Inc.'s acquisition of Greater Atlantic Health Services, Inc.,
Health Partners of Alabama, Inc.'s acquisition of the Georgia and Alabama
operations of Physician Corporation of America, Harvard Pilgrim Health Plan's
proposed acquisition of Matthew Thornton Health Plan (which offer was
terminated), Humana, Inc.'s acquisition of Health Direct Insurance, Inc.,
Foundation Health System, Inc.'s acquisition of Advantage Health, and Foundation
Health System, Inc.'s investment in First Option Health Plan of New Jersey, Inc.
Multiples of revenue and price per member (stated on a commercial full risk HMO
member equivalent basis) were calculated.
The average multiples for the transactions analyzed were then
discounted to reflect, inter alia, the small size of PHPNJ compared to the
target companies involved in the transactions analyzed, and the lack of any
other assets included in the Transaction such as goodwill associated with the
PHPNJ name or fixed assets. The adjusted averages were applied to PHPNJ's latest
twelve months' revenues and membership as of the latest quarter end (March 3l,
1997) with a resulting BEV reference range of approximately $1.0-1.8 million.
Shattuck Hammond concluded that an appropriate BEV reference range for
PHPNJ would lie at the lower end of the calculated range, due to a number of
significant negative factors including PHPNJ's low enrollment and small capital
base compared to its competitors in the New Jersey market, its recent
significant operating losses, and narrow product portfolio. Hence, a BEV of
$1.0-1.5 million was deemed appropriate by Shattuck Hammond.
No company, transaction or business included in the "Selected Public
Company Analysis" or the "Selected Merger and Acquisition Transactions Analysis"
as a comparison is identical to PHPNJ or the Transaction. Accordingly an
analysis of the results of the foregoing analyses cannot be mathematical or
precise; rather it involves complex considerations and judgments concerning
differences in financial and operating characteristics and other factors that
could affect the acquisition,
17
<PAGE>
public trading or other values of the selected companies, the selected
transactions or the company or transactions with which they are being compared.
Shattuck Hammond then calculated the estimated value of the
consideration to PHPNJ from the Purchaser for the Transaction. The consideration
(the "Consideration" ) consists of three components: (1) a cash payment equal to
the greater of: (a) $1,000,000 or (b) $300.00 per HMO member on the Closing Date
(the "Cash Payment"); plus (2) a contingent payment equal to $10.00 for each
eligible Health Care Payers Coalition ("HCPC" ) life to whom the services of the
Purchaser's network of providers are available on the one year anniversary of
the Closing Date; plus (3) the estimated economic benefit to PHPNJ of the
Management Fee Accommodation (hereinafter defined) being charged to PHPNJ by the
Purchaser.
Shattuck Hammond noted that the Purchaser paid a $500,000 "good faith"
deposit (the "Deposit") into an interest bearing escrow account maintained at
Mellon Bank, N.A. as Escrow Agent. Upon closing, the Deposit shall be
transferred to PHPNJ and credited against the Cash Payment to determine the net
additional cash required to be paid by the Purchaser to PHPNJ at closing. Any
interest earned on the Deposit inures to the benefit of PHPNJ, assuming the
closing of the Transaction. Due to the small amount of expected interest
earnings on the Deposit, Shattuck Hammond did not include the estimated earned
interest in its calculation of the value of the total Consideration. The total
estimated value of the Consideration, calculated as discussed below, was then
compared by Shattuck Hammond to the calculated BEV reference ranges to assess
the fairness, from a financial point of view, of the Transaction to the
stockholders of PHPNJ.
Estimation of Cash Payment. Since the Cash Payment will be based on
PHPNJ's HMO enrollment as of the Closing Date, it is not possible to determine
exactly the amount of the Cash Payment. However, if membership does not fall
below the level of March 31, 1997 (5,443 members), the Cash Payment will be
$1,637,900. If membership levels of May 31, 1997 are maintained (6,122 members),
the Cash Payment will be $1,836,600. The Cash Payment is subject to a minimum of
$1,000,000 even if membership declines below 3,333. Hence, the estimated range
of the Cash Payment was estimated by Shattuck Hammond as $1.0-1.8 million.
Estimation of Contingent Payment. Because there are no assurances or
requirements that a relationship between HCPC and the Purchaser will be in place
one year after the Closing Date, and because PHPNJ will not be in a position to
facilitate such relationship, Shattuck Hammond assigned no economic value to the
Contingent Payment.
Estimated Economic Benefit of the Management Fee Accommodation. The
Purchaser, pursuant to the Management Services Agreement, agreed to provide,
either directly or through subcontract, substantially all administrative and
management services to PHPNJ, except for reporting to the SEC or any related
Federal and State reporting required under the securities laws of the United
States or the State of New Jersey. The management fee payable to the Purchaser
for such services (the "Management Fee Accommodation" ) is $15.00 per member per
month ("PMPM") for each HMO member enrolled in PHPNJ as of the first day of each
month. In the event the stockholders of
18
<PAGE>
PHPNJ disapprove of the Agreement within six months of July 1, 1997, the
management fee shall be increased to $25.00 PMPM (the "Increased Management Fee"
), effective either as of the date PHPNJ's stockholders disapprove the Agreement
or retroactively to date which is 61 days from July 1, 1997, whichever occurs
earlier. In the event the stockholders have not voted on the Agreement by
January 1, 1998, the Increased Management Fee shall commence with the January 1,
1998 payment. The Management Services Agreement terminates on the first to occur
of (a) the Closing Date or (b) 60 days after the earlier of either (i) the date
the PHPNJ stockholders disapprove the Agreement, or (ii) January 1,1998.
Shattuck Hammond considered the Purchaser to be a qualified provider of
administrative and management services due to, inter alia, its strong capital
base (net worth of $40.0 million at March 31, 1997) and its experience in
managing and operating its own HMO, one of the largest in New Jersey with
267,487 members as of March 31, 1997. For purposes of its analysis, Shattuck
Hammond assumed that the Transaction closes by December 31, 1997, that the
Management Services Agreement took effect on July 1, 1997, and that the
Purchaser provides administrative and management services to PHPNJ consistent
with the terms of the Management Services Agreement, since it is not possible to
estimate the total economic impact on PHPNJ if the Purchaser either failed to
perform the services as provided in the Management Services Agreement or
terminated the Management Services Agreement pursuant to the cancellation
provisions of the agreement.
The economic benefit of the Management Fee Accommodation to PHPNJ was
calculated by comparing the $15.00 PMPM Management Fee Accommodation to the
estimated administrative and management costs which would have been incurred by
PHPNJ if the Management Services Agreement had not been entered into as part of
the Transaction. Since PHPNJ had specified to parties interested in submitting
proposals to purchase or affiliate with PHPNJ that they should be prepared to
assume the management duties of MGM, the costs to terminate the MGM Contract,
pursuant to the terms of the MGM Contract, were not dependent on the identity of
the proposer or the structure of their proposal. Hence, Shattuck Hammond
considered the costs involved in terminating the MGM Contract to be a
transaction cost and therefore irrelevant to its estimation of the economic
benefit of the Management Fee Accommodation.
The Company provided Shattuck Hammond with data showing that the costs
incurred by PHPNJ for the equivalent administration and management services to
be provided by the Purchaser were $27.16 PMPM on an assumed member base of
6,000, (which is in line with average levels during May and June 1997). This
cost of $27.16 PMPM includes, among other costs, MGM fees and full time and
temporary administrative personnel, with benefits assumed to equal 40% of
payroll, (which are "pass through" costs to PHPNJ), but excludes rent and the
costs of equipment leasing. Some of the costs, e.g. telecommunications and
triage line, are not charged on a PMPM basis, so if one were to assume
enrollment lower than 6,000 members, the PMPM cost of administering the plan
before entering into the Management Services Agreement would be higher than
$27.16 PMPM.
Based on assumed PHPNJ membership levels of 6,000, Shattuck Hammond
calculated the monthly economic benefit to PHPNJ of the Management Fee
Accommodation to be $72,960 ($27.16-$15.00 x 6,000 members = $72,960). Shattuck
Hammond assumed monthly savings of
19
<PAGE>
$70,000 multiplied by a range of 3-6 months during which the Management Services
Agreement is expected to be in effect prior to closing. Hence, the range of
economic benefit to PHPNJ of the Management Fee Accommodation is estimated at
$210,000-420,000.
Shattuck Hammond then aggregated its estimates of the three components
of Consideration and determined that the expected value of Consideration range
of $1.2-2.3 million compared favorably to the estimated BEV reference range for
PHPNJ.
Other Factors and Comparative Analyses. The preparation of fairness
opinions involves various determinations as to the most appropriate and relevant
quantitative and qualitative methods of financial analyses and the application
of those methods to the particular circumstances. Accordingly, such opinions are
not readily susceptible to summary description. In arriving at its opinion,
Shattuck Hammond did not attribute any particular weight to any analysis or
factor considered by it, but rather made qualitative judgments as to the
significance and relevance of each analysis and factor. Shattuck Hammond,
therefore, believes its analyses must be considered as a whole and that
considering any portion of such analyses, without considering all analyses and
factors as a whole, could create a misleading or incomplete view of the process
underlying the opinion which it rendered.
Shattuck Hammond was retained by the PHPNJ Board on the basis of its
experience as financial advisors in connection with mergers and acquisitions.
The Board retained Shattuck Hammond to provide an opinion to the Board as to the
fairness of the Transaction to the stockholders of PHPNJ from a financial point
of view, pursuant to a supplemental letter agreement executed on July 30, 1997.
Pursuant to that agreement, the Board agreed to pay Shattuck Hammond a fee of
$100,000 upon the delivery of its Fairness Opinion. The Board also agreed to
reimburse Shattuck Hammond for expenses including fees and expenses of its legal
counsel incurred by it and to indemnify Shattuck Hammond for certain liabilities
that may arise out of the rendering of its services or opinions.
Shattuck Hammond is a nationally recognized investment banking firm. As
part of its investment banking business, Shattuck Hammond is continually engaged
in the valuation of businesses and their securities in connection with mergers
and acquisitions, negotiated underwritings, secondary distributions of
securities, private placements and other purposes. Shattuck Hammond had provided
certain investment banking services to PHPNJ from time to time prior to its
engagement to render the opinion discussed above, including (i) for fees
totaling $70,000, advisory services provided to PHPNJ in analyzing potential
strategic acquisitions and in analyzing and evaluating potential sources of
capital and/or strategic affiliation options; and (ii) pursuant to an engagement
letter dated March 20, 1997 (the "March 1997 Engagement Letter" ) financial
advisory services to PHPNJ in soliciting indications of interest from third
parties in a possible acquisition of, investment in, or partnership with PHPNJ,
and in analyzing and evaluating the proposals received and for advising PHPNJ in
connection with the Transaction. Compensation to Shattuck Hammond for such
services was as follows: $10,000 paid upon signing of the March 1997 Engagement
Letter; $10,000 per month during the term of the engagement; $15,000 upon
signing of a letter of intent between PHPNJ and $50,000
20
<PAGE>
upon signing of the Agreement; and $55,000 which is payable upon consummation of
the Transaction.
Required Regulatory Approvals
The transaction contemplated by the Agreement requires the approval of
the New Jersey Department of Health and Senior Services and the New Jersey
Department of Banking and Insurance. To obtain such approvals, the Purchaser is
required to submit to these regulatory agencies an application to amend its
Certificate of Authority so that such Certificate will cover the operations that
the Purchaser proposes to assume pursuant to the Agreement. Such application
must be accompanied by additional information required by either Department in
connection with proposed acquisitions of substantially all of the assets of a
health maintenance organization. Approval of the Agreement is still pending as
of the date hereof. The Department of Banking and Insurance also must approve
the Management Services Agreement between the Company and the Purchaser, and the
form of notices regarding the transaction which are required to be sent to
providers, members of the Plan and group contract holders. As of the date
hereof, the Department of Banking and Insurance has approved the Management
Services Agreement subject to the concurrence of the Department of Health and
Senior Services.
On July 9, 1997 and July 23, 1997, representatives of the Company,
BCBSNJ and the Purchaser met with representatives of the Department of Health
and Senior Services and the Department of Banking and Insurance of New Jersey
for the purpose of outlining the proposed terms of the transaction, and
discussing the requirements and possible timing for obtaining the approvals of
the Departments and the process of transferring the Contracts to the Purchaser.
The Purchaser estimates that the required filings will be made by September 30,
1997. Although the Purchaser believes that regulatory approvals for similar
types of transactions customarily are received 30-60 days after required filings
are made, no assurance can be given that the applicable regulatory agencies will
approve the proposed transaction by that time, if at all, or that such
regulatory agencies will not require modifications to the terms of the
transaction. In the event that the substance of the transaction as contemplated
by the Agreement or the amount of the purchase price described therein is
materially modified as a result of requirements imposed by applicable regulatory
authorities, the Company would consider whether supplemental proxy materials
must be delivered to stockholders and, if such regulatory requirements are
imposed after the date of the Special Meeting of Stockholders, whether
subsequent action by the stockholders is necessary.
Use of Proceeds
The Company will apply the proceeds received pursuant to the Agreement
to the payment of claims incurred but not reported prior to the Closing Date.
21
<PAGE>
Accounting Treatment of the Transaction
The proceeds, less any associated expenses, related to the sale of the
Contracts will be recorded as a realized gain by the Company upon approval of
the transaction by the stockholders and the state regulators. In addition, the
Company will record an additional realized gain, if any, for the receipt of $10
for each remaining HCPC member on the first anniversary of the Closing Date.
Tax Consequences of the Transaction
The proceeds received by the Company will be treated as a capital gain.
However, the Company believes that such gain will be offset by current year
operating losses and, therefore, the Company does not anticipate paying taxes on
the gain. The transaction does not result in tax consequences for the
stockholders.
Management Arrangements with the Purchaser
In addition to purchasing the Contracts, the Purchaser provides
substantially all management and administrative services necessary for the
operation of the Company's business, pursuant to a Management Services Agreement
by and between the Company and the Purchaser, dated as of June 26, 1997 and
effective as of July 1, 1997. The Management Services Agreement is not subject
to approval by the stockholders of the Company, but is subject to approval by
state regulators. See "Required Regulatory Approvals".
As of July 1, 1997 (the "Commencement Date"), the Purchaser assumed
responsibility for providing substantially all management and administrative
services necessary for the operation of the Company's business, including but
not limited to claims processing, member services, enrollment, provider
assistance, utilization management and financial services including accounting
and reporting for all product lines of the Company's business. The Purchaser
does not provide any services relating to any reporting to the Securities and
Exchange Commission or other securities authorities. The Purchaser is permitted
to provide management services through subcontractors if it so elects. The
Company believes it has effected an orderly transition of management to the
Purchaser from Medical Group Management, Inc., the company which previously
provided management services to the Company.
The Management Services Agreement will terminate at the first to occur
of (a) the Closing Date, or (b) 60 days after (i) the date that the stockholders
of the Company vote but do not approve the Agreement or (ii) the six month
anniversary of the Commencement Date if the stockholders of the Company have
failed to vote on the Agreement during such six month period.
In consideration for providing management services, the Company pays
the Purchaser a management fee of $15 per member per month for each HMO member
enrolled in the Plan as of the first day of each month. The $15 per member per
month rate applies through the Closing Date; however, if the Company's
stockholders do not approve the Agreement or fail to take action within
22
<PAGE>
six months of the Commencement Date, then the management fee will be increased
to $25 per member per month, effective as of the date that the stockholders
voted but did not approve the Agreement, or 61 days from the Commencement Date,
whichever occurs earlier.
If the Purchaser fails materially to perform under the Management
Services Agreement and fails to cure the default within 30 days, the Company may
terminate the Management Services Agreement and has all rights and remedies
available at law or in equity. If the Company fails to pay the management fee
or, in the Purchaser's reasonable good faith judgment, puts significant barriers
in the way of the Purchaser assuming or performing any of its obligations under
the Management Services Agreement, and fails to cure such default within 30
days, then the Purchaser may terminate the Management Services Agreement and has
all rights and remedies available at law or in equity.
Post-Transaction Events
After the Closing Date, the Company will be required to maintain its
Certificate of Authority and minimum statutory net worth, and to cover its
liabilities incurred prior to the Closing Date. The Company will surrender its
Certificate of Authority to the State of New Jersey in accordance with
applicable regulatory requirements, at such time as the New Jersey Department of
Banking and Insurance shall approve. Such approval will not be given until the
New Jersey Department of Banking and Insurance is satisfied that all claims for
services provided prior to the Closing Date have been satisfied or provided for.
At this time, the Company is unable to determine the amount of liabilities which
it may be required to pay up to the Closing Date. The amount of the Company's
liabilities will depend primarily upon the amounts of claims for covered
services performed prior to the Closing Date and submitted for payment after the
Closing Date.
After the surrender of the Certificate of Authority, it is expected
that the Company will be liquidated and assets remaining, if any, after
satisfaction of the Company's liabilities will be distributed to stockholders.
Amounts distributed in respect of each outstanding share of the Company's common
stock are expected to be substantially lower than the purchase price paid by
stockholder for such share. However, the Company is unable to estimate at this
time what amounts, if any, would be available for distribution. Liquidation
would require additional stockholder action but would not occur for at least one
year after Closing Date because the Company will receive the Subsequent
Installment of the purchase price on the first anniversary of the Closing Date.
BUSINESS
Overview
The Company is a New Jersey corporation, formed on January 10, 1994
under the sponsorship of private practicing physicians for the purpose of
developing a statewide physician- owned and directed health maintenance
organization. In December 1994, the Company filed an application for a
Certificate of Authority to operate as an HMO in five counties in New Jersey,
which application was approved effective August 28, 1995. The Company was not
permitted to solicit
23
<PAGE>
business until a Certificate of Authority was obtained. The Company commenced
marketing its HMO plans to persons living in the five county area and issued its
first policy in November 1995. In September 1995, the Company filed an
application to amend its Certificate of Authority to expand its service area to
cover the entire State of New Jersey. The amendment was approved effective
January 29, 1996. The Company received federal trademark registration for its
name, for the acronym PHPNJ and for the stylized "P" logo which contains a
cut-out in the shape of New Jersey.
On March 4, 1994, the Company commenced an initial offering for the
purpose of raising capital necessary to fund operations until the Company
received its Certificate of Authority and subsequently to fund operational
deficits until such time as the Company began operating at a profit. On November
9, 1995, the Company commenced a second offering for the purpose of expanding
the Company's existing network of physicians, expanding the Company's programs
and infrastructure and enhancing the Company's capital position. The initial
offering resulted in proceeds of approximately $17,500,000 and the second
offering resulted in proceeds of approximately $6,250,000.
The Company devoted substantial efforts to developing and credentialing
its healthcare delivery network, and health plans particularly for the small
employer marketplace in New Jersey. As of September 1, 1997, the Company had
entered into approximately 1,400 Physician Participation Agreements with
physicians who have been credentialed, and 81 contracts with inpatient care
facilities. In addition, the Company has negotiated contracts for the provision
of certain ancillary services such as prescription benefits. The Company has
developed HMO, preferred provider organization ("PPO") and point-of-service
("POS") products. As of September 1, 1997, the Company had 6,257 members
enrolled in its plans, with approximately 81% of such members enrolled in a POS
plan.
Since inception, the Company has engaged a management company to
provide substantially all management and administrative services, including but
not limited to, financial services, member and provider support services,
provider credentialing, and claims processing. Until July 1997, the Company was
managed by Medical Group Management, Inc. ("MGM"), a subsidiary of the New
Jersey State Medical Underwriters, Inc., which in turn is a subsidiary of the
Medical Society of New Jersey. Currently, the Purchaser provides substantially
all of the management and administrative services necessary for the operation of
the Company's business. See "PROPOSAL TO APPROVE AGREEMENT RELATING TO THE
PURCHASER OF THE HMO AND PPO OPERATIONS OF THE COMPANY AND RELATED MATTERS -
Management Arrangements with the Purchaser" and "MANAGEMENT'S PLAN OF
OPERATIONS." In addition, the Company has a contract with The Pace Group, Inc.
to provide certain additional administrative services. See "MANAGEMENT'S PLAN OF
OPERATIONS."
Notwithstanding the Company's efforts to develop its healthcare plans
and a membership base, the Company has experienced significant competitive
pressures in its marketplace resulting in the Company's inability to become
profitable. In 1997, the Company has added only 2,183 members.
24
<PAGE>
To the extent that members do not renew their policies as the terms of such
policies end in the third and fourth quarters of this year, premium revenues
would be even more adversely affected.
Strategic Initiatives
By April 1996, the Company's leadership recognized the impact of
changing market conditions, coupled with attendant network, pricing and product
issues, and acknowledged that membership goals were not being met and that
expenses were being incurred in excess of the Company's revenues. The Company
developed a three-part strategy to improve operating results. The components of
that strategy were: (a) capital preservation, (b) marketing and sales, and (c)
new product initiatives. To preserve capital, the Company implemented a new
staffing model which reduced monthly salaries and compensation expenses
beginning in September, 1996. Staffing was reduced and sales efforts were
shifted from a staff of sales employees to a broker-driven sales effort. In
addition, the Company reduced the amount of space it leased, effective October
1, 1996, and cut its monthly advertising budget by approximately two-thirds. The
Company proposed to develop special marketing arrangements with local medical
communities, and currently markets one of its existing products under a
marketing arrangement called "Skyland Select."
Notwithstanding the implementation of this strategy, the Company has
continued to incur losses. Early in 1997, the Company's leadership charged the
Board of Directors' Due Diligence Committee with identifying strategic options
and recommending a course of action that would be most beneficial to the Company
and its stockholders, ultimately resulting in the negotiation of the Agreement
and Management Services Agreement with HMO Blue. In addition, the Company has
sold most of its fixed assets to MGM, sold certain equipment to HMO Blue, and
sold its automobiles to other parties. See "PROPOSAL TO APPROVE AGREEMENT
RELATING TO THE PURCHASE OF THE HMO AND PPO OPERATIONS THE COMPANY AND RELATED
MATTERS - Reasons for Engaging in the Transaction" and "MANAGEMENT'S PLAN OF
OPERATIONS."
Health Plans and Healthcare Delivery System
The Company has entered into Physician Participation Agreements with
credentialed stockholders of the Company for the provision of physician
services. In addition, the Company has entered into contracts with other
physicians or physician groups to provide services to the Company and its
members, where the Company has deemed such to be necessary to provide high
quality patient care or to meet competitive conditions. The Company also has
contracted with non-stockholder physicians who have begun their private
practices within the last two years. Under the Physician Participation
Agreements, participating physicians are paid pursuant to a pre-established fee
schedule. Such physicians are prohibited from billing members for services
provided under the plan, except for any applicable co-payment or deductible.
25
<PAGE>
The Company has contracted with acute care institutions. The Company
arranges for the delivery of necessary preventive, diagnostic, therapeutic, and
rehabilitation healthcare services to its members by contracting with qualified
non-physician providers. These contracts provide for reimbursement at
pre-determined rates on a discounted fee-for-service basis and prohibit these
providers from billing members for any services paid under the plan, except for
applicable co-payments or deductibles.
The Company's health plans consist of HMO and POS plans for the small
business marketplace (less than 50 employees) and the large business marketplace
(50 or more employees), offered on a fully-insured basis, subject to certain
co-payments, where the Company bears the risk for incurred medical costs in
exchange for premiums paid. Members receive comprehensive medical coverage for a
prepaid fixed monthly premium. The plans offered meet the standard benefit plan
requirements as set forth in New Jersey Laws and Regulations. Generally, the
products are distinguished from one another by the amount of the applicable
co-payment and prescription rider.
Premium rates are fixed for a twelve-month period. Rate increases must
be submitted to the New Jersey Department of Banking and Insurance, and there
can be no assurance that rate increases will be accepted without objection. Such
increases are generally effective on the renewal date of the policyholder's
policy. Renewal dates vary among policyholder groups. The Company utilizes a
system of rating adjusted by class with respect to groups of 50 or more members
and a community rating system for small groups (2 - 49 members) in determining
its rates for various employers in the proposed service area. Accordingly, rates
can vary among employer groups for coverage under the same Company plan.
Proposed rates for basic healthcare coverage required by New Jersey must be
submitted to the New Jersey Department of Banking and Insurance and the New
Jersey Small Employer Health Benefit Board.
Under the Company's prepaid health plans, each new member is required
to select a Primary Care Physician from a directory supplied by the Company. All
medical care thereafter received by the member, including specialist and
hospital care, is coordinated by the Primary Care Physician who is familiar with
the member's history. Pre-authorization is required for non-emergency hospital
admissions, diagnostic and selected outpatient procedures. Such
pre-authorization is obtained in accordance with pre-established guidelines
developed by management in conjunction with physicians in the respective
specialty areas. Variations from pre-established protocols are evaluated by peer
physicians. Management believes that such physician-to-physician consulting
results in a high quality of care for its members. Except for co-payments and
applicable deductibles, the Company covers all other charges for treatment at
emergency rooms of non-participating hospitals in the event of a medical
emergency or urgently needed services.
The Company has established comprehensive utilization management
protocols and quality assurance standards. The Utilization Management Program is
designed to objectively monitor and evaluate the use, cost and quality of
medical services provided by the Company's physicians and other healthcare
consultants and facilities. The goal is to efficiently use available healthcare
resources and to ensure that care is medically appropriate. The Quality
Assurance Program includes policies and
26
<PAGE>
procedures for credentialling providers, assessing member and provider
satisfaction annually, and obtaining other quality measurement data.
Each participating physician is required to carry current malpractice
insurance coverage. The minimum acceptable level as set by the Company is $1
million per incident and $3 million in the aggregate for any given calendar
year. In addition, the Company carries contingent medical malpractice liability
coverage.
The Company uses a number of marketing techniques to attract and retain
members, key elements of which are: advertising and public relations, brokerage
sales, and "Member Services" assistance. The Company's sales efforts have been
directed at mid-sized businesses (50 - 500 employees) and small businesses
(fewer than 50 employees). Sales are handled primarily by brokers. During 1996,
the Company shifted its sales strategy from direct sales to broker-driven sales
as part of the capital preservation strategy to reduce expenses. Member Services
provides customer service to members, employers who are policyholders and
brokers and consultants.
Competition
The Company competes with other prepaid health plans and with
traditional health insurers in its geographic area, as well as with self-insured
programs, physician practice associations and other managed care entities. As of
December 31, 1996, the New Jersey commercial HMO market consisted of twenty-one
(21) organizations, eleven (11) of which have been operational for at least
three (3) years.
The Company believes the most significant differences among competing
health care plans are the extent of covered services, the cost of coverage, the
degree of access to health care providers, and the perception of the convenience
and quality of care delivered to enrollees. Premiums negotiated with employers,
fee schedules negotiated with hospitals, physicians and other providers, the
scope of benefits offered, unique benefit design and access to physicians and
hospitals constitute the principal methods of competition.
The goals of the Company are to offer the highest quality medical care
through a broad range of physicians and to ensure access to care for the
Company's members. The Company was formed, in part, to address the concerns
raised by patients and their doctors that many of the existing managed care
plans take medical decisions away from the physician and place them under the
control of the insurance company. The Company places control of medical
decisions in the hands of the physicians, who collaborate in developing quality
assurance and utilization management guidelines.
Many of the Company's competitors have had significantly greater
financial and marketing resources than the Company. The Company has encountered
difficulty attracting members and group contracts because larger competitors
have been able to be more competitive in premium pricing. In addition, the
Company's short history of operations relative to its competitors has made it
difficult for the Company to attract group contracts, particularly from large
employers.
27
<PAGE>
Government Regulation
HMOs are subject to extensive regulation. In New Jersey, the Department
of Health and Senior Services and the Department of Banking and Insurance are
the governing regulatory authorities. Among areas regulated are the scope of
benefits required to be made available to members, reserves required to be
maintained, plan design, procedures for review of quality assurance, enrollment
requirements, the relationship between the HMO and its physicians and other
healthcare providers and the financial condition of the HMO. A Certificate of
Authority to operate as an HMO is required in New Jersey. An HMO is subject to
triennial review by state regulators and must submit certain annual and
quarterly reports to the state.
Legislation enacted in New Jersey includes provisions to enroll
individuals and, to some extent, small groups or be subject to assessments if
market share quotas are not achieved. In addition, New Jersey has mandated
standard benefit packages to be sold to these markets and has regulated the
rates that may be charged as well as the methodology to be used in developing
the rates. The Company has designed products to meet these requirements. Other
provisions include guaranteed issue and renewability, without regard to
utilization, as well as minimum medical loss ratios, participation and
contribution requirements. Other restrictions and requirements could be imposed
that would affect HMO operations generally, the products offered by the Company
or other aspects of healthcare. Such restrictions might result in additional
burdens and costs to the Company.
Under New Jersey law, an HMO must satisfy a minimum net worth
requirement of $1,500,000 to obtain a Certificate of Authority and must
establish a restricted deposit of $300,000 with the New Jersey Department of
Banking and Insurance. The deposit amount is adjusted annually based on the
HMO's net worth. In addition, a New Jersey HMO must maintain a reserve in an
amount to provide for all claims incurred plus continued health care services to
members. If the Company should fail to meet the foregoing deposit and minimum
net worth requirements, the Company's Certificate of Authority might be revoked.
Both federal and New Jersey law prohibit physicians from paying or
receiving any remuneration, directly or indirectly, for the referral of a
patient. In addition, state law (with certain exceptions) and federal law, under
certain defined circumstances, prohibit referral by a physician to a health care
entity in which the physician or his immediate family has a financial interest.
The Company believes that neither the Company nor its physician stockholders are
in violation of either the federal or New Jersey law as a result of the
operation of or participation in the Company's HMO. To the extent that
physicians refer patients to other physicians, the referring physicians receive
no remuneration from such referral. Moreover, the Company does not require or
encourage physicians to refer patients to entities in which they have a
financial relationship.
Antitrust concerns have become central issues in the new managed care
environment of the health care industry. Whenever physicians or other health
care providers join together to form ventures for the delivery of health care
services, antitrust issues may be present. The Company has
28
<PAGE>
attempted to take all steps possible to minimize any antitrust risk.
Nevertheless, the law in this area is unsettled and very fact specific.
It is impossible to predict whether further federal and/or state
legislation will be adopted or to quantify the impact that such legislation
might have on the healthcare delivery system and the Company.
In the June 30, 1996 Quarterly Statement filed with the New Jersey
Department of Banking and Insurance, the Company reported a loss of $4.86
million for the six-month period then ended. State regulations require the
Department of Banking and Insurance to meet with management of any HMO reporting
two consecutive quarters of operating losses and to work with that management to
determine (a) the cause for the loss, (b) the strategy to reverse the loss, and
(c) the projected impact of that strategy on the HMO's net worth. The Company's
leadership met with the Department of Banking and Insurance in September 1996,
to discuss its strategies and projections for future operations.
In March 1997, Company representatives met with personnel from the
Department of Banking and Insurance to review the Company's financial
performance for the preceding two fiscal quarters, and to provide the Department
with projected financial statements for the following four fiscal quarters.
After the March meeting, the Department required the following additional
reporting from the Company: (a) monthly profit and loss statements, (b)
quarterly itemized listings of all administrative costs greater than $10,000 per
quarter, to be filed with the Company's Quarterly Statements, and (c) pro forma
financial statements for the Company's proposed Medicare line of business,
including a description of assumptions used.
The Company has filed all required information with the Department of
Banking and Insurance subsequent to the September 1996 and March 1997 meetings,
and the Company continues to report progress on its strategies to the Department
of Banking and Insurance. After the March 1997 meeting, the Company determined
to put the development of a Medicare product on hold.
As described elsewhere in this Proxy Statement, the transaction
contemplated by the Agreement is subject to approval by the Department of Health
and Senior Services and the Department of Banking and Insurance.
Employees
The Company presently has no employees. Under the previous management
agreement with MGM, and under the current Management Services Agreement with the
Purchaser and agreement with Pace, all management and administrative services
necessary for the operation of the Company have been provided by contract
personnel.
29
<PAGE>
Property
Effective July 31, 1997, the Company vacated space that it previously
subleased from MGM in an office building located in Princeton Pike Corporate
Center, 1009 Lenox Drive, Building 4, in Lawrenceville, New Jersey. The
Company's obligation to pay rent for such space terminated on June 30, 1997. The
Company has no leased or owned real property.
Legal Proceedings
There are no legal proceedings pending against the Company which, if
successful, would materially adversely affect the operations or financial
condition of the Company.
INTEREST OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON
[THREE] of the Company's directors have a relationship with BCBSNJ or
its affiliates. However, each of these directors has advised the Company that
his relationship does not result in any direct or indirect substantial interest
in the matters to be acted upon by the stockholders of the Company. Director
Barry Prystowsky, M.D. is a member of the Credentials Committee of [HMO BLUE].
Director Martin S. Levine, D.O. is the Medical Director of Compsource, the
workers' compensation affiliate of BCBSNJ. [DIRECTOR ALEXANDER R. HOROWITZ, M.D.
HAS APPLIED FOR A MEDICAL DIRECTOR POSITION WITH BCBSNJ.]
Each director is a party to a Physician Participation Agreement with
the Company, which may be assumed by the Purchaser. Therefore, each director is
expected to become a participating physician in HMO Blue and to receive
compensation from the Purchaser in the future in an amount equal to the
predetermined rates for physician services provided, which amount would be the
same as that received by any similarly situated physician participating in HMO
Blue.
SECURITIES OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
As of the Record Date, each director owns one share of the Company's
common stock, or approximately 0.02 percent of the shares outstanding as of the
Record Date. As a group, directors own approximately 0.4 percent of the shares
as of the Record Date. Each director has sole voting and investment power with
respect to the share that he or she owns. The Company's acting chief executive
officer and chief financial officer do not own any shares. The Company is not
aware of any person or group owning more than five percent of the shares.
30
<PAGE>
FINANCIAL STATEMENTS
Index to Financial Statements
Page
----
Report of Independent Auditors 32
Balance Sheets as of December 31, 1996 and 1995 33
Statements of Operations for the Years Ended December 31, 1996 34
and 1995
Statements of Changes in Stockholders' Equity for the Years Ended 35
December 31, 1996 and 1995
Statements of Cash Flows for the Years Ended December 31, 1996 36
and 1995
Notes to Financial Statements at December 31, 1996 and 1995 37
Balance Sheets as of June 30, 1997 (unaudited) and 46
December 31, 1996
Statements of Operations for the Three Months Ended June 30, 1997 47
and 1996 (unaudited)
Statements of Operations for the Six Months Ended June 30, 1997 48
and 1996 (unaudited)
Statements of Changes in Stockholders' Equity for the Six Months Ended 49
June 30, 1997 and the Year Ended December 31, 1996 (unaudited)
Statements of Cash Flows for the Six Months Ended June 30, 1997 and 50
1996 (unaudited)
Notes to Financial Statements at June 30, 1997 and 1996 51
31
<PAGE>
Report of Independent Auditors
The Board of Directors
Physician Healthcare Plan of New Jersey, Inc.
We have audited the accompanying balance sheets of Physician Healthcare Plan of
New Jersey, Inc. as of December 31, 1996 and 1995, and the related statements of
operations, stockholders' equity and cash flows for the years then ended. These
financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Physician Healthcare Plan of
New Jersey, Inc. at December 31, 1996 and 1995, and the results of its
operations and its cash flows for the years then ended in conformity with
generally accepted accounting principles.
ERNST & YOUNG LLP
Hackensack, New Jersey
March 28, 1997
32
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
BALANCE SHEETS
DECEMBER 31
1996 1995
---- ----
ASSETS
Current assets:
Cash and cash equivalents $ 5,563,345 $ 5,308,465
Short-term investments 1,307,185 3,980,627
Advances to management company 430,929 23,723
Reinsurance recoverable on claims payable 300,000
Prepaid and other current assets 321,714 228,627
------------ ------------
Total current assets 7,923,173 9,541,442
Investments 2,651,139 565,723
Furniture and equipment, net 1,320,867 1,757,018
Deferred offering costs 450,000
Other assets 18,107 50,000
------------ ------------
Total assets $ 11,913,286 $ 12,364,183
============ ============
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities:
Claims payable $ 1,544,647 $ 1,862
Accounts payable and accrued expenses 782,428 831,855
Funds held for reinsurer 328,789
Other liabilities 85,679 15,433
------------ ------------
Total liabilities 2,741,543 849,150
Stockholders' equity:
Common stock, subject to redemption
(no par; 20,000 authorized;
4,636 and 3,515 issued and
outstanding) 23,750,222 17,575,000
Paid-in capital 43,214 24,838
Net unrealized (loss) gain on investments (5,476) 21,645
Accumulated deficit (14,616,217) (6,106,450)
------------ ------------
Total stockholders' equity 9,171,743 11,515,033
------------ ------------
Total liabilities and stockholders' equity $ 11,913,286 $ 12,364,183
============ ============
See accompanying notes
33
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
STATEMENTS OF OPERATIONS
YEAR ENDED DECEMBER 31
1996 1995
---- ----
REVENUE
Premiums, net of reinsurance $ 2,167,345 $ 2,223
Interest income, net 641,869 709,742
Other revenue 51,429 21
------------ ------------
Total revenue 2,860,643 711,986
EXPENSES
Medical costs 2,012,747 2,075
Professional services 3,345,965 2,007,982
Compensation and benefits 3,195,984 1,947,499
General and administrative 1,923,002 1,313,620
Insurance 192,712 106,922
------------ ------------
Total expenses 10,670,410 5,378,098
------------ ------------
NET LOSS $ (7,809,767) $ (4,666,112)
============ ============
NET LOSS PER COMMON SHARE $ (1,846) $ (1,318)
============ ============
See accompanying notes
34
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
Years ended December 31, 1996 and 1995
<TABLE>
<CAPTION>
NET
UNREALIZED
(LOSS) GAIN
COMMON PAID-IN ON ACCUMULATED STOCKHOLDERS'
STOCK CAPITAL INVESTMENTS DEFICIT EQUITY
----- ------- ----------- ------- ------
<S> <C>
BALANCE AT
JANUARY 1,
1995 $ 17,750,000 $ -- $ -- $ (1,440,338) $ 16,309,662
Common
stock redeemed
(35 shares) (175,000) 24,838 (150,162)
Net unrealized 21,645 21,645
gains
Net loss (4,666,112) (4,666,112)
------------ ------------ ------------ ------------ ------------
BALANCE AT
DECEMBER 31,
1995 17,575,000 24,838 21,645 (6,106,450) 11,515,033
Common stock
issued 6,250,222 (700,000) 5,550,222
Common stock
redeemed
(15 shares) (75,000) 18,376 (56,624)
Net unrealized (27,121) (27,121)
losses
Net loss (7,809,767) (7,809,767)
------------ ------------ ------------ ------------ -----------
BALANCE AT
DECEMBER 31,
1996 $ 23,750,222 $ 43,214 $ (5,476) $(14,616,217) $ 9,171,743
============ ============ ============ ============ ============
</TABLE>
See accompanying notes
35
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
YEAR ENDED DECEMBER 31
1996 1995
---- ----
<S> <C>
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss $ (7,809,767) $ (4,666,112)
Adjustments to reconcile net loss to net cash used in
operating activities:
Depreciation and amortization 569,007 133,327
Loss on disposal of furniture and equipment 1,356
Changes in operating assets and liabilities:
Advances to management company (407,206) 488,244
Prepaid and other current assets (93,087) (137,681)
Other assets 31,893 (50,000)
Reinsurance recoverable on claims payable (300,000)
Funds held for reinsurer 328,789
Claims payable 1,542,785 1,862
Accounts payable and accrued expenses (49,427) 454,355
Other liabilities 70,246 15,433
------------ ------------
NET CASH USED IN OPERATING ACTIVITIES (6,115,411) (3,760,572)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of equipment (282,562) (1,860,823)
Proceeds from sale of furniture and equipment 6,699
Cost of investments acquired (3,197,444) (4,809,255)
Proceeds from investments matured 3,900,000 12,515,000
------------ ------------
NET CASH PROVIDED BY INVESTING ACTIVITIES 426,693 5,844,922
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from stock issuance 6,250,222
Offering costs (250,000) (450,000)
Redemption of common stock (56,624) (150,162)
------------ ------------
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 5,943,598 (600,162)
------------ ------------
Net increase in cash and cash equivalents 254,880 1,484,188
Cash and cash equivalents, beginning of year 5,308,465 3,824,277
------------ ------------
CASH AND CASH EQUIVALENTS, END OF YEAR $ 5,563,345 $ 5,308,465
============ ============
</TABLE>
See accompanying notes
36
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 1996
1. ORGANIZATION AND RELATED MATTERS
Physician Healthcare Plan of New Jersey, Inc. (the "Company"), a New Jersey
corporation, was formed January 10, 1994, under the sponsorship of private
practicing physicians for the purpose of developing a statewide, physician-owned
Health Maintenance Organization ("HMO"). The Company's Certificate of Authority
("COA") to operate as an HMO in five counties in New Jersey was approved on
August 28, 1995. In September 1995, the Company filed an amendment to its COA to
operate in the remaining counties in New Jersey, which was approved January 29,
1996. The Board of Directors, comprised solely of stockholders, oversees the
operations of the Company.
The Company's health plans consist of HMO plans and point-of-service (POS)
plans, offered on a fully-insured basis, whereby members receive comprehensive
medical coverage for a fixed monthly premium. Medical services are provided
through discounted fee-for-service participation agreements with physicians and
various per diem or fee-for-service contracts with hospitals and other
providers. Under regulations adopted in April 1996, the Company filed a
comprehensive small group POS product which the Company began marketing upon
filing of policy forms approved by the New Jersey Department of Banking and
Insurance.
On March 4, 1994, the Company had an initial offering to physicians both
practicing and residing in New Jersey, for the purpose of raising capital
necessary to fund its operations until the Company received its COA and
subsequently to fund operational deficits until such time as the Company begins
to operate at a profit. See Note 5 for a further description of the initial
offering.
The Company's registration statement for the second offering was filed with the
Securities and Exchange Commission (the "SEC") and declared effective on
November 9, 1995. The second offering of shares to physicians practicing in the
State of New Jersey was for the purpose of expanding the Company's existing
network of physicians, expanding the Company's programs and infrastructure and
enhancing the Company's equity position. See Note 5 for a further description of
the second offering.
The Company has incurred significant operating losses in 1996 and 1995. The very
competitive nature of the New Jersey managed care marketplace continues to
present ongoing challenges to the Company's ability to achieve the subscriber
(enrolled member) levels necessary to generate acceptable levels of
profitability. Management believes the Company has sufficient capital to fund
operations over the next twelve months.
37
<PAGE>
2. SIGNIFICANT ACCOUNTING POLICIES
BASIS OF PRESENTATION
The financial statements have been prepared in conformity with generally
accepted accounting principles ("GAAP"). The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosures of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenue and expenses during the reporting period. Actual
results could differ from those estimates.
NEW ACCOUNTING STANDARD
In March 1995, the Financial Accounting Standards Board (FASB) issued Statement
of Financial Accounting Standards ("SFAS") No. 121, Accounting for the
Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of,
effective for fiscal years beginning after December 15, 1995. Statement No. 121
requires long-lived assets and certain intangibles to be reviewed for impairment
whenever circumstances indicate that the carrying amount of an asset may not be
recoverable. Long-lived assets and certain intangibles to be disposed of are
required to be reported at the lower of carrying amount or fair value less cost
to sell. In 1996, approximately $212,000 of capitalized system development costs
were written off.
INVESTMENTS
SFAS No. 115, Accounting for Certain Investments in Debt & Equity Securities,
requires that securities be classified in one of three categories. Debt
securities that the Company has the intent and ability to hold to maturity would
be classified as held to maturity and reported at amortized cost. Debt
securities that are held for resale would be classified as trading securities
and reported at fair value with unrealized gains and losses included in
earnings. Debt securities not so classified are considered available for sale
and reported at fair value with unrealized gains and losses included in
stockholders' equity. The Company's investments in debt securities are
classified as available-for-sale and are carried at fair value.
Investment income, net of investment expenses and amortization of bond premium
and discount, is recognized in income when earned.
FURNITURE AND EQUIPMENT
Furniture and equipment is carried at cost less accumulated depreciation.
Depreciation is calculated using the straight-line method over the useful lives
of the depreciable assets which range from three to five years. As of December
31, 1996 and 1995, accumulated depreciation on furniture and equipment was
$838,015 and $133,801, respectively. Depreciation expense totaled $710,658 and
$133,327 for the years ended December 31, 1996 and 1995, respectively.
38
<PAGE>
OFFERING COSTS
Costs incurred of $450,000 in connection with the second offering (see Note 5)
had been capitalized at December 31, 1995. In 1996, additional second offering
costs of $250,000 were incurred. In 1996, the deferred costs amounting to
$700,000 were reclassified into stockholders' equity and reflected as a
reduction of the actual proceeds from the second offering.
REVENUE RECOGNITION
Premiums from members for prepaid health care are recognized as income in the
period in which the enrollees are entitled service. Premiums collected in
advance are recorded as advance premiums and are included in other liabilities
on the balance sheets.
MEDICAL COSTS
Medical costs consist of medical claims costs which are accrued in the period
that services are provided to members. Medical costs include estimates for
claims incurred by the Company and which have not yet been reported ("IBNR").
Such estimates are continually monitored and reviewed and, as settlements are
made or estimates adjusted, the resulting differences will be reflected in the
current period of operations. Since the Company recently began operations and
lacks its own historical experience, the estimate for IBNR is in part based on
currently available industry ratios for claims expense to premiums earned.
Despite the variability inherent in such estimates, management believes that the
liability for medical claims payable is adequate.
ADVERTISING
The Company expenses their advertising costs as they are incurred. In 1996 and
1995, advertising expense was approximately $1,100,000 and $120,000
respectively.
INCOME TAXES
The Company accounts for income taxes in accordance with SFAS No. 109,
Accounting for Income Taxes. SFAS No. 109 prescribes an asset and liability
method for accounting for deferred taxes, the objective of which is to recognize
an asset or liability for the expected future tax effects due to temporary
differences between financial reporting and tax basis of assets and liabilities,
based on enacted tax rates and other provisions of the tax law. The principal
items giving rise to such differences are net operating loss carry forwards,
start-up and organizational costs and furniture and equipment. Under SFAS No.
109, deferred tax assets are recognized unless it is more likely than not that
some portion of the deferred tax assets may not be realized.
NET LOSS PER COMMON SHARE
Net loss per common share is based upon the weighted average number of shares
outstanding during the year.
39
<PAGE>
CASH FLOW REPORTING
For purposes of reporting cash flows, cash and cash equivalents includes all
cash on deposit, money market accounts and investments purchased with an
original remaining maturity of three months or less.
RECLASSIFICATION
Certain balances presented in the 1995 financial statements have been
reclassified to conform to the 1996 presentation.
3. MANAGEMENT AGREEMENT
Effective September 1, 1994, the Company entered into a Management Agreement
(the "Management Agreement") with Medical Group Management, Inc. ("MGM"), a
subsidiary of New Jersey State Medical Underwriters, Inc. ("NJSMU"). The
Management Agreement provides, among other things, that MGM is responsible for
all administration and management of the Company. NJSMU provides management,
accounting, regulatory, legal and data processing support to MGM.
The Management Agreement may be terminated by either party given 180 days
written notice. The Company has the option of extending the termination period
for an additional 180 days at its discretion. Under certain circumstances, if
the Company terminates the Agreement with MGM, a termination fee (penalty) may
be payable to MGM as defined in the Management Agreement. In February 1997, the
Company and MGM agreed to amend the notification date for the renewal option
from March 1, 1997 to June 1, 1997.
The Management Agreement is for a three-year period and expires August 31, 1997.
The Management Agreement calls for a fixed payment per month for management,
oversight and development. The Company incurred and paid $600,000 and $850,000
of management fees to MGM for the years ended December 31, 1996 and 1995,
respectively. In addition to the fixed payment, all costs incurred by MGM on
behalf of the Company are reimbursed. Costs incurred by MGM under this
agreement, including management fees, which have been reimbursed by the Company
totaled $7,673,387 and $4,464,188 for the years ended December 31, 1996 and
1995, respectively.
4. COMMITMENTS AND CONTINGENCIES
OPERATING LEASES
The Company leases office facilities and office equipment. During 1995, the
Company entered into a six year lease to rent office facilities. Effective
October 1, 1996, NJSMU has assumed the Company's obligation under this lease and
has subleased 33% of the facility back to the Company under terms consistent
with the original lease. Minimum rental commitments for noncancelable leases,
exclusive of escalations due to real estate taxes and operating expenses are as
follows:
40
<PAGE>
1997 $186,417
1998 187,429
1999 177,667
2000 184,000
2001 62,333
Thereafter -
--------
$797,846
========
Total rent expense for all leases was $416,642 and $239,730 for the years ended
December 31, 1996 and 1995, respectively.
ADMINISTRATIVE CONTRACTS
Since May 30, 1995, the Company has operated under a letter of intent with
Acordia of Southern California ("Acordia") to provide the Company's
administrative and management information systems. The initial term of the
proposed contract is two years with an automatic one year renewal without 120
days prior notice of termination by either party. The Company may terminate at
any other time with 30 days prior notice. Under the terms of this agreement, the
Company will continue to pay Acordia a per member per month fee.
DIVIDENDS
New Jersey state law provides that dividends or other distributions may be paid
only from retained earnings and to the extent statutory capital and surplus is
in excess of the minimum net worth requirement of $1,000,000. As of December 31,
1996, the Company's statutory capital and surplus was $8,674,736. The Company
has not paid and does not intend to pay any dividends for the foreseeable
future.
OTHER
As of December 31, 1996, the Company's investments include restricted assets on
deposit with the State of New Jersey for solvency protection totaling $305,244.
In addition, at December 31, 1996 the Company has a letter of credit relating to
its leased office space which is collateralized with a certificate of deposit in
the amount of $250,000.
5. CAPITAL STOCK
On March 4, 1994, the Company sought to raise capital through an initial
offering of up to 15,000 shares of stock at a price of $5,000 per share to
physicians who were eligible purchasers. Only physicians who both practiced and
resided in the State of New Jersey were eligible purchasers. The Company issued
3,569 shares as a result of this Offering, representing $17,845,000 in initial
capital.
41
<PAGE>
The Company's registration statement was filed with the SEC and declared
effective November 9, 1995. The purpose of the second offering to physicians who
practice in the State of New Jersey was to raise additional capital of up to
10,000 shares of stock at a price of $5,500 per share. All shares have the same
rights and privileges. In 1996, the Company issued 1,136 shares as a result of
this offering, representing $6,250,222 of additional capital.
In order to ensure the Company operates as a physician-owned HMO whereby
stockholders represent participating physicians in the HMO, the Articles of
Incorporation and By-Laws provide certain restrictions on this stock. It is
non-transferable and can only be redeemed by the Company. Circumstances
requiring redemption of stock at current book value in order to preserve the
integrity of the network include death, retirement, disability, loss of license
to practice medicine in New Jersey and termination of an effective Physician
Participation Agreement with the Company. In addition, physicians who fail to
become credentialed by the Company must redeem their shares at the original
purchase price without interest. As of December 31, 1996, 90% of the physicians
from the Initial and Secondary Offerings have been credentialed. Physicians who
otherwise wish to redeem their shares may do so at the sole discretion of the
Board of Directors at current book value. After approval, the Board may take up
to six months to redeem such shares. The Company shall not be required to redeem
a stockholder's stock if the Company is insolvent, if doing so would cause the
Company to become insolvent, or if the Company is, or the redemption would cause
the Company to be, in a precarious financial condition.
6. EMPLOYMENT COSTS
The Company currently has no direct employees. All persons providing services on
behalf of the Company are employees of MGM or NJSMU. MGM provides a
comprehensive benefits package for these employees, the amount of which is
included in total compensation and benefits costs.
7. RELATED PARTY TRANSACTIONS
The stockholders and directors of the Company are and will continue to be
physicians who have entered into participating provider agreements with the
Company. Accordingly, a large portion of the claims payable and incurred medical
costs are due to stockholders. Also, at December 31, 1996 1,388 or 34% of the
Plan's members related to stockholders who have placed their practice's medical
coverage with the Plan.
On March 13, 1997, the Company agreed to reimburse the former Chairman of the
Board of Directors $100,000 for his loss of income and out of pocket expenses
incurred during his term as Chairman. Such amount has been reflected in the 1996
Statement of Operations.
8. INVESTMENTS
DEBT SECURITIES
The following summarizes the amortized cost and the estimated fair value of the
Company's investments in debt securities as of December 31, 1996 and 1995. The
estimated fair values for the Company's investments in debt securities are based
on quoted market prices.
42
<PAGE>
GROSS -- UNREALIZED
AMORTIZED --------------------- ESTIMATED
COST GAINS LOSSES FAIR VALUE
----------------------------------------------------
1996
- ----
U.S. treasury and
other governmental
units $3,713,800 $ 381 $5,857 $3,708,324
Other debt securities 250,000 250,000
----------------------------------------------------
Total investments $3,963,800 $ 381 $5,857 $3,958,324
====================================================
1995
- ----
U.S. treasury and
other governmental
units $4,274,705 $21,645 $4,296,350
Other debt securities 250,000 250,000
----------------------------------------------------
Total investments $4,524,705 $21,645 $ - $4,546,350
====================================================
The following summarizes the amortized cost and estimated fair value of the
Company's investments in debt securities by contractual maturity as of December
31, 1996:
AMORTIZED ESTIMATED
COST FAIR VALUE
---------------------------
Maturity:
Within one year $1,306,989 $1,307,185
After one year through five years 2,656,811 2,651,139
---------------------------
Total investments $3,963,800 $3,958,324
===========================
The Company's investments in debt securities are comprised of investment grade
securities, with the highest credit ratings assigned by Standard & Poor's (AAA)
or Moody's (Aaa;P-1), respectively.
43
<PAGE>
9. INCOME TAXES
The Company has not provided any current or deferred income taxes for the years
ended December 31, 1996 or 1995.
The income tax provision differs from the amount computed by applying the
statutory federal income tax rate to the net loss. The reasons for the
difference and the tax effect of each are as follows for the years ended
December 31, 1996 and 1995:
% OF PRE-
TAX NET LOSS
-------------------
1996 1995
-------------------
Tax based on statutory federal income tax rate (34.0)% (34.0)%
Deduct:
Valuation allowance to reduce deferred tax asset 36.5 33.8
Other (2.5) .2
-------------------
Total income taxes 0.0% 0.0%
===================
The components of deferred taxes as of December 31, 1996 and 1995 are as
follows:
1996 1995
--------------------------------
Net operating loss $ 4,597,000 $ 1,940,000
Other 104,000 26,000
Depreciation 52,000 (70,000)
--------------------------------
Net deferred tax assets 4,753,000 1,896,000
Valuation allowance (4,753,000) (1,896,000)
--------------------------------
Net deferred tax assets $ -- $ --
================================
The valuation allowance has been recorded due to the uncertainty of the
realization of the deferred tax assets since the realization of such benefits
would be dependent upon achieving future operating profits which cannot be
reasonably assured.
At December 31, 1996, net operating loss carryforwards are approximately
$13,520,000. Of the net operating loss carryforwards, $7,498,000, $5,189,000 and
$833,000 expire in 2011, 2010 and 2009, respectively.
44
<PAGE>
10. REINSURANCE
The Company entered into a specific excess of loss reinsurance agreement with an
admitted AAA rated reinsurer with a retention limit of $35,000 per member per
year. Under the terms of the agreement, the Company pays a per member per month
premium in exchange for reimbursement of medical claims exceeding the retention
limit. The Company has not recorded any reinsurance recoveries related to this
agreement. In the event of the Company's insolvency, the reinsurer will continue
to pay for services for the duration of the contract period for which payment
has been made, not to exceed 31 days or until the time of discharge for members
confined in an inpatient facility on the date of insolvency.
In 1996, the Company entered into an additional arrangement with a reinsurer to
cover 100% of the out-of-network claims incurred related to the POS product.
Such arrangements are required by New Jersey regulations as preconditions for
underwriting POS products. The Company is currently renegotiating an extension
of this POS reinsurance contract which expires on March 31, 1997. At December
31, 1996, approximately 74% of the Company's direct premiums earned came through
POS products.
Amounts recorded in 1996 related to the above arrangements are summarized as
follows:
Premiums ceded, net of experience refund earned $537,129
Ceded loss recoveries 300,000
Ceding commission income 75,232
For both arrangements discussed above, the Company remains primarily liable as
the direct insurer on all risks reinsured. In addition, all of the Company's
reinsurance is placed with a single reinsurer.
45
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
BALANCE SHEETS
June 30, December 31,
1997 1996
---- ----
Unaudited
ASSETS
Current assets:
Cash and cash equivalents $ 3,971,628 $ 5,563,345
Short-term investments 498,750 1,307,185
Advances to management company 414,973 430,929
Reinsurance recoverable on claims payable 345,984 300,000
Prepaid and other assets 272,097 321,714
------------ ------------
Total current assets 5,503,432 7,923,173
Investments 2,465,502 2,651,139
Furniture and equipment, net 304,487 1,320,867
Other assets -- 18,107
------------ ------------
Total assets $ 8,273,421 $ 11,913,286
============ ============
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities:
Claims payable $ 2,568,702 $ 1,544,647
Accounts payable and accrued expenses 839,926 782,428
Funds held for reinsurer 261,415 328,789
Other liabilities 205,703 85,679
------------ ------------
Total liabilities 3,875,747 2 ,741,543
------------ ------------
Stockholders' equity:
Common Stock, subject to redemption 23,729,922 23,750,222
(no par; 20,000 authorized; 4,631
and 4,636 issued and outstanding)
Paid in capital 66,690 43,214
Net unrealized loss on investments (11,865) (5,476)
Accumulated deficit (19,387,073) (14,616,217)
------------ ------------
Total stockholders' equity 4,397,674 9,171,743
------------ ------------
Total Liabilities and Stockholders' Equity $ 8,273,421 $ 11,913,286
============ ============
See accompanying notes
46
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
STATEMENTS OF OPERATIONS
(UNAUDITED)
For the Three For the Three
Months Ended Months Ended
June 30, 1997 June 30, 1996
------------- -------------
REVENUE
Premiums, net of reinsurance $ 2,160,040 $ 235,393
Interest income, net 83,367 126,084
Other revenue 27,366 12,742
----------- -----------
Total revenue 2,270,773 374,219
----------- -----------
EXPENSES
Medical costs 3,077,077 189,846
Professional services 1,242,481 976,115
Compensation and benefits 314,126 854,335
General and administrative 394,595 532,275
Provision for loss on
furniture and equipment 760,000 --
Insurance 38,109 48,378
----------- -----------
Total expenses incurred 5,826,388 2,600,949
----------- -----------
NET LOSS $(3,555,615) $(2,226,730)
=========== ===========
NET LOSS PER COMMON SHARE $ (768) $ (506)
=========== ===========
See accompanying notes.
47
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
STATEMENTS OF OPERATIONS
(UNAUDITED)
For the Six For the Six
Months Ended Months Ended
June 30, 1997 June 30, 1996
-------------- -------------
REVENUE
Premiums, net of reinsurance $ 4,216,303 $ 328,549
Interest income, net 287,918 253,361
Other revenue 70,811 13,138
----------- -----------
Total revenue 4,575,032 595,048
----------- -----------
EXPENSES
Medical costs 4,719,203 269,409
Professional services 2,335,949 2,089,064
Compensation and benefits 689,238 1,743,522
General and administrative 768,471 1,100,143
Provision for loss on
furniture and equipment 760,000 --
Insurance 73,027 97,656
----------- -----------
Total expenses incurred 9,345,888 5,299,794
----------- -----------
NET LOSS $(4,770,856) $(4,704,746)
=========== ===========
NET LOSS PER COMMON SHARE $ (1,030) $ (1,188)
=========== ===========
See accompanying notes.
48
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
Six Months Ended June 30, 1997 and the Year Ended December 31, 1996
<TABLE>
<CAPTION>
NET
UNREALIZED
(LOSS)GAIN
COMMON PAID-IN ON ACCUMULATED STOCKHOLDERS'
STOCK CAPITAL INVESTMENTS DEFICIT EQUITY
----- ------- ----------- ------- ------
<S> <C>
BALANCE AT $17,575,000 $24,838 $ 21,645 $ (6,106,450) $11,515,033
DECEMBER 31,
1995
Common stock 6,250,222 (700,000) 5,550,222
issued, net
Common stock (75,000) 18,376 (56,624)
redeemed (15 shares)
Net unrealized losses (27,121) (27,121)
Net loss (7,809,767) (7,809,767)
----------- ------- -------- ------------- -----------
BALANCE AT
DECEMBER 31, 23,750,222 43,214 (5,476) (14,616,217) 9,171,743
1996
Common stock, (20,300) 23,476 3,176
redeemed, net
(5 shares)
Net (6,389) (6,389)
unrealized losses
Net loss (4,770,856) (4,770,856)
----------- ------- -------- ------------ ----------
BALANCE AT $23,729,922 $66,690 $(11,865) $(19,387,073) $ 4,397,674
JUNE 30, 1997 =========== ======= ======== ============ ===========
</TABLE>
See accompanying notes.
49
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
STATEMENTS OF CASH FLOWS
(UNAUDITED)
<TABLE>
<CAPTION>
For the Six For the Six
Months Ended Months Ended
June 30, 1997 June 30, 1996
------------- -------------
<S> <C>
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss $(4,770,856) $(4,704,746)
Adjustment to reconcile net loss to net cash used
for operating activities:
Loss on disposal of furniture and 760,000 --
Equipment
Depreciation and amortization 143,788 283,112
Advances to management company 15,956 (1,699,362)
Prepaid and other assets 49,617 81,976
Accounts payable and accrued expenses 57,498 623,885
Claims payable 1,024,055 160,365
Reinsurance recoverable on unpaid losses (45,984) --
Other liabilities 120,024 66,182
Other assets 18,107 --
Funds held for reinsurer (67,373) --
----------- -----------
NET CASH PROVIDED BY (USED IN) OPERATING
ACTIVITIES (2,695,168) (5,188,588)
----------- -----------
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from sale of equipment 20,373 --
Purchase of equipment -- (127,710)
Proceeds from investments matured 3,517,675 --
Cost of investments acquired (2,437,773) --
----------- -----------
NET CASH PROVIDED BY (USED IN ) INVESTING
ACTIVITIES 1,100,275 (127,710)
----------- -----------
CASH FLOWS FROM FINANCING ACTIVITIES
Common stock subscribed -- 5,729,850
Redemption of common stock 3,176 (5,349)
----------- -----------
NET CASH PROVIDED BY FINANCING
ACTIVITIES 3,176 5,724,501
----------- -----------
Net increase (decrease) in cash and cash (1,591,717) 408,203
equivalents
Cash and cash equivalents, beginning of period 5,563,345 5,308,465
----------- -----------
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 3,971,628 $ 5,716,668
=========== ===========
</TABLE>
See accompanying notes
50
<PAGE>
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 1997
(UNAUDITED)
1. UNAUDITED FINANCIAL STATEMENTS
The financial information for the three and six months ended June 30,
1997 and 1996 included herein is unaudited. Such information includes all
adjustments, consisting of a normal and recurring nature, which in the opinion
of management, are necessary for a fair presentation of the Company's Balance
Sheets, and Statements of Operations, Changes in Stockholders' Equity and Cash
Flows in accordance with generally accepted accounting principles. Such
information should be read in conjunction with Management's Plan of Operation
included herein on page 54 and the Notes to Financial Statements for the year
ended December 31, 1996 on page 37. The interim operating results are not
necessarily indicative of the operating results for the full fiscal year.
2. SALE OF GROUP CONTRACTS AND PROVIDER AGREEMENTS
In an agreement dated June 26, 1997 (the "Agreement"), the Company
contracted to assign and transfer to Medigroup of New Jersey, Inc. (the
"Purchaser" or "HMO Blue") provider agreements and all group contracts in return
for consideration based on HMO and PPO membership, but not less than $1 million.
This transaction is conditioned upon the receipt of approvals from various
parties, including, but not limited to, the Company's shareholders, the
Commissioner of Health and Senior Services, and the Commissioner of Banking and
Insurance of the State of New Jersey. In addition, Blue Cross and Blue Shield of
New Jersey, Inc. ("BCBSNJ") has agreed to appoint certain physicians selected by
the Company to several BCBSNJ and HMO Blue committees and to the board of HMO
Blue's parent company. The Purchaser is a wholly owned subsidiary of Medigroup,
which in turn is a wholly owned subsidiary of BCBSNJ, and the Purchaser operates
an HMO in the State of New Jersey known as "HMO Blue".
3. MANAGEMENT AGREEMENT
Effective September 1, 1994, the Company entered into a management
agreement with Medical Group Management, Inc. ("MGM"), a subsidiary of New
Jersey State Medical Underwriters, Inc. ("NJSMU"). The management agreement with
MGM provided, among other things, that MGM was responsible for all
administration and management of the Company.
Effective July 1, 1997, the Company entered into a Management Services
Agreement (the "Management Agreement") with the Purchaser. Under the terms of
the Management Agreement, the Purchaser will provide the Company management and
administrative services necessary for the operation of the Company including,
but not limited to, claims processing, member services, enrollment, provider
assistance, utilization management and financial services. The cost of such
services will be based upon a per HMO member per month fee, and will be lower
than management fees previously paid by the Company.
51
<PAGE>
In addition, the Company expects to engage The Pace Group, Inc.
("Pace") to provide certain management transition services and certain corporate
financial and reporting assistance not otherwise provided by the Purchaser. The
Company will pay Pace a retainer of $20,000 per month, applied against hourly
billings for services and expenses.
Following the execution of the Management Agreement, the Company
entered into negotiations with MGM to terminate the previous management
agreement. In the interest of facilitating management transition, the Company
expects the termination of the management agreement with MGM to be effective as
of July 31, 1997.
4. SALE OF FIXED ASSETS
With the Purchaser's assumption of responsibility for management and
administrative services through the Management Agreement, the Company has
proposed to sell to MGM its fixed assets, chiefly furniture and computer
equipment at its office location in Lawrenceville, New Jersey. MGM has offered
approximately $260,000 for the Company's fixed assets, based primarily on a
series of appraisals obtained from independent third party appraisal firms. The
Company expects to close on the sale of fixed assets to MGM in a transaction to
be effective as of July 31, 1997. Based on June 30, 1997 net book values for
those fixed assets, the Company has recorded a $760,000 provision for loss on
furniture and equipment during the three months ended June 30, 1997.
5. COMMITMENTS AND CONTINGENCIES
The Company leases office facilities and office equipment. Effective
October 1, 1996, NJSMU assumed the Company's obligation under the office
facilities lease and subleased 33% of the facility back to the Company under
terms consistent with the original lease. As of the July 31, 1997 effective date
of the termination of the MGM management agreement, the Company expects that the
month-to-month lease for 9,351 square feet at 1009 Lenox Drive, Lawrenceville,
New Jersey will be terminated and the Company will have no further obligation
under such lease. Upon such termination, the Company will not occupy any space
at any location.
6. REINSURANCE
The Company entered into a specific excess of loss reinsurance
agreement with an admitted AAA rated reinsurer with a retention limit of $35,000
per member per year. Under the terms of the agreement, the Company pays a per
member per month premium in exchange for reimbursement of medical claims
exceeding the retention limit. The Company has not recorded any reinsurance
recoveries related to this agreement. In the event of the Company's insolvency,
the reinsurer will continue to pay for services for the duration of the contract
period for which payment has been made, not to exceed 31 days or until the time
of discharge for members confined in an inpatient facility on the date of
insolvency.
In 1996, the Company entered into an additional arrangement with a
reinsurer to cover 100% of the out-of-network claims incurred related to the
Point-of-service ("POS") product. Such arrangements are required by New Jersey
regulations as preconditions for underwriting POS products. For both
arrangements, the Company remains primarily liable as the direct insurer on all
risks reinsured. In addition, all of the Company's reinsurance is placed with a
single reinsurer.
52
<PAGE>
In April 1997 the Company renewed its reinsurance coverage under
similar terms effective through December 31, 1997. With the announcement of the
Agreement, the reinsurer has given notice of its intent to cancel the policy
based on management changes. That cancellation is effective August 31, 1997.
Management will seek to renew the reinsurance without a lapse in coverage, but
expects that any such renewal would occur at a somewhat higher premium.
53
<PAGE>
MANAGEMENT'S PLAN OF OPERATION
Six Months Ended June 30, 1997
The Company is a New Jersey corporation, formed on January 10, 1994
under the sponsorship of private practicing physicians for the purpose of
developing a statewide, physician-owned Health Maintenance Organization ("HMO").
As of June 30, 1997, the number of shares outstanding from the
Company's 1994 initial offering and the 1996 second offering of common stock is
4,631, resulting in net paid-in capital of $23,796,612.
In addition to filing quarterly reports required of all New Jersey
HMO's by the New Jersey Department of Banking and Insurance (the "Department"),
the Company has continued to provide monthly reports to the Department,
describing progress toward membership and financial goals, which the Department
required as a result of a March 1997 meeting to review the Company's financial
performance.
As described in Note 2 of the Notes to Financial Statements at June 30,
1997 the Company has contracted to assign and transfer provider agreements and
all group contracts to the Purchaser, subject to shareholder and regulatory
approvals. At the closing of such transaction, it is expected that the Company
will wind down its operations and, ultimately, surrender its Certificate of
Authority to the Department at such time as the Department is satisfied that all
claims and liabilities arising prior to the date of closing of the transaction
have been paid or provided for. The Company is unable to estimate at this time
when such surrender would occur or what assets, if any, would be available for
distribution to stockholders after the Company ceases operations.
As noted in Note 4 of the Notes to Financial Statements at June 30,
1997 the Company has proposed to sell to MGM its furniture and equipment. The
Company also proposes to sell 8 automobiles, and has authorized MGM to effect
such sales.
The Company expects that it will sell to the Purchaser certain office
equipment and file cabinets for a price of approximately $4,000. In addition,
the Company expects that, in connection with the Purchaser's performance of
management services, as described in Note 3 of the Notes to Financial Statements
at June 30, 1997, the Company will permit the Purchaser to use certain computer
equipment and related property in return for the Purchaser maintaining the
equipment, paying for insurance for the equipment and assuming the risk of loss
or damage.
During the three months ended June 30, 1997, the Company's revenues
increased from the comparable 1996 fiscal period by $1,896,554, with $1,924,647
attributable to increased enrollment in the HMO and Point-of-Service ("POS")
products sold by the Company. The increase in premium revenue was partially
offset by lower interest income attributable to declining investment balances
over the preceding fiscal periods. Results for 1996 reflected limited sales
dependent on the timing of the Company's COA approval by the Department in early
1996. At June 30, 1997, the Company reported total enrollment of 6,257 members,
compared to only 880 at June 30, 1996. As reported in prior periods, the Company
continues to record approximately 80% of member-months (each representing one
enrollee for one month of coverage) in its POS products. Notwithstanding the
54
<PAGE>
increase in enrollment, the Company has not met its targets for enrollment
because of significant competitive pressures in its marketplace.
Medical costs increased $2,887,224 from the comparable 1996 fiscal
period reflecting the enrollment increase described earlier, coupled with a
recent increase in claims payments. In May and June, 1997, claims payments
experienced a substantial increase to approximately $888,000 and $1,036,000,
respectively, compared to an average of $324,000 per month for the period
January-April, 1997. Those increased claims payments have resulted from
increases in the number of claims per member, and increases in the average cost
per claim. In addition to increased utilization of medical services by the HMO
membership, weekly reporting from the claims processor identified reductions in
claims inventory during this period.
As in prior periods the Company recorded its IBNR claims reserve based
on an evaluation of the Company's historical data by an independent actuary. The
claims reserve recorded by the Company is at the high end of the actuary's
suggested range.
As noted in Note 6 of the Notes to Financial Statements at June 30,
1997, the Company's reinsurer has given notice of its intent to cancel the
Company's reinsurance policies based on management changes effective August 31,
1997. Management will seek to renew the reinsurance without a lapse in coverage,
but expects that any such renewal would occur at a somewhat higher premium. No
assurance can be given that coverage can be renewed on terms acceptable to the
Company. Any failure to renew coverage could have a material adverse effect on
the Company's ability to write POS coverage in the future.
No tax benefits for operating losses have been recognized in the
financial statements because the realization of such benefits would be dependent
upon achieving future operating profits, which cannot be reasonably assured.
All other expense categories (Professional services, Compensation and
benefits, General and administrative, and Insurance) decreased a total of
$411,523 from the comparable 1996 fiscal period, primarily reflecting (a)
reduced advertising, (b) reduced permanent staffing partially offset by
consultants and other temporary staffing, and (c) reduced occupancy costs
resulting from an assignment-sublease arrangement effective October 1, 1996. As
noted in Note 4 of the Notes to Financial Statements at June 30, 1997, the
Company recorded a Provision for Loss on Furniture and Equipment of $760,000,
reflecting its intent to dispose of fixed assets that will no longer be needed
at the best available price based upon a series of independent appraisals.
During the first six months of 1997, the Company incurred a net loss of
$4,770,856, with operations requiring the use of $2,695,168 in cash. The Company
obtained the funds to finance its operating deficit by withdrawing $1,591,717
from Cash and cash equivalents, $808,425 from Short-term investments, and
$185,637 in Investments. In addition the Company incurred the $760,000 write-off
described in Note 4 of the Notes to Financial Statements at June 30, 1997,
reflecting the appraised value of fixed assets no longer needed for Company
operations which have been turned over to the Purchaser. The new Management
Agreement with the Purchaser is described in Note 3 of the Notes to Financial
Statements at June 30, 1997. Taken together these changes account for the
$3,639,865 decline in total assets. The State of New Jersey imposes a minimum
net
55
<PAGE>
worth requirement of $1,000,000. As of June 30, 1997, the Company's statutory
net worth was $4,323,843, or approximately $3.3 million above the minimum.
The Board of Directors of the Company approved on July 15, 1997 a
resolution to place a moratorium on redemptions of the Company's common stock
for any reason, including reasons set forth in the Company's by-laws, because of
the prospect that the satisfaction of all prospective redemption obligations
could cause the Company to be in "precarious financial condition" as that term
is defined in the Company's prospectus dated November 9, 1995 and included in
the Company's registration statement on Form SB-2, SEC file no. 33-94826-NY. As
a result, the Company will not be required to redeem a stockholder's shares of
the Company's common stock in the event that the stockholder requests such
redemption in connection with an event described in the Company's by-laws, or in
connection with the failure of the Company to credential the stockholder as a
provider under the Company's health care plans, or for any other reason.
Recent Developments
Effective July 31, 1997, the Company's management agreement with MGM
was terminated by mutual consent, and MGM and the Company released each other
from all further obligations and liabilities. The Company was not required to
pay any termination or other fee in connection with the termination of the
agreement. Also effective as of July 31, 1997, MGM purchased the furniture and
equipment as described in Note 4 of the Notes to Financial Statements as of June
30, 1997, for a purchase price of $262,077. During July 1997, the Company's
eight automobiles were sold for an aggregate purchase price of approximately
$70,000.
Effective July 14, 1997, the Company entered into an agreement with The
Pace Group, Inc. to provide management transition services and certain corporate
financial and reporting assistance, as described in Note 3 of the Notes to
Financial Statements as of June 30, 1997.
The Company has renewed its reinsurance coverage to cover claims
incurred through December 31, 1997 or the Closing Date, whichever occurs first,
and paid within an additional 90 days. The Company's premiums will not increase
but management believes that the scope of risk assumed by the reinsurer has
decreased slightly compared to the previous terms of coverage.
MARKET PRICE AND DIVIDEND INFORMATION
There is no public market for the common stock of the Company. The
Company's shares may only be purchased by physicians who are licensed to
practice medicine and surgery in New Jersey and who are actively practicing.
Each stockholder is limited to one share. The By-Laws of the Company prohibit
the transfer of stock to any person or entity, to ensure that only physicians
participating in the network maintain ownership in the Company. However, the
By-Laws provide for mandatory redemption by the Company in exchange for the book
value of the stock upon the occurrence of certain events, such as death,
retirement, disability, loss of medical license, cessation of practice in New
Jersey and termination of an effective Physician Participation Agreement between
the Company
56
<PAGE>
and the physician stockholder. Discretionary redemption by the Board of
Directors is also permitted. Additionally, the Physician Participation Agreement
is expressly conditioned on the physician being credentialed. If the physician
is not initially credentialed, the physician agrees that his or her stock shall
be redeemed by the Company for the purchase price paid, without interest. If the
Company has not made a decision regarding the initial credentialing of a
stockholder within twelve (12) months of the Company's receipt of such
stockholder's purchase price, upon request of such stockholder, the Company will
redeem such stock for the purchase price, without interest.
The Company is not permitted to redeem a share if the Company is
insolvent or if doing so would cause the Company to be in a precarious financial
condition, as determined by the Board of Directors. In November 1996, the Board
of Directors adopted a resolution to the effect that discretionary redemptions
would not be made for a period of 12 months after the adoption of such
resolution. In July 1997, the Board of Directors adopted a resolution that
placed a moratorium on all redemptions, for any reason, to prevent a potentially
large redemption obligation from causing the Company to be in precarious
financial condition.
The Company has not paid any dividends and does not intend to pay
dividends for the foreseeable future. Earnings, if any, have been retained for
use in the operation and expansion of the Company's business. Additionally, the
Company must obtain approval from the New Jersey Department of Banking and
Insurance prior to declaring any dividends.
INDEPENDENT PUBLIC ACCOUNTANTS
Since 1994 Ernst & Young, LLP, has served as the Company's independent
public accountants. Representatives of Ernst & Young are expected to be present
at the Special Meeting.
OTHER MATTERS
The Board of Directors is not aware of any other matters that may come
before the meeting. If any other business properly comes before the meeting, the
persons designated as proxies will vote upon such matters in their discretion.
AVAILABLE INFORMATION
The Company is subject to the information requirements of the
Securities Exchange Act of 1934, as amended, and, in accordance therewith, files
reports, proxy statements and other information with the Securities and Exchange
Commission (the "Commission"). The public may inspect and copy at prescribed
rates such reports, and other information that the Company has filed with the
Commission, at the public reference facilities that the Commission maintains at
450 Fifth Street, N.W., Washington, D.C. 20549 and at the Commission's regional
offices located at 500 West Madison Street, Suite 1400, Chicago, Illinois 60661
and Seven World Trade Center, 13th Floor, New York, New York 10048. In addition,
the public may obtain such reports and other information concerning the Company
from the Public Reference Section of the Commission at its Washington,
57
<PAGE>
D.C. address upon payment of prescribed fees. The Commission also maintains a
web site that contains reports, proxy statements and other information regarding
registrants that file electronically with the Commission. The address of such
site is http://www.sec.gov.
By order of the Board of Directors
/s/ Bessie Sullivan, M.D.
Secretary
September 30, 1997
STOCKHOLDERS WHO DO NOT EXPECT TO ATTEND THE MEETING ARE
REMINDED TO MARK, SIGN, DATE AND RETURN THE ENCLOSED PROXY IN THE
POSTAGE PAID ENVELOPE PROVIDED.
58
<PAGE>
EXHIBIT A
---------
AGREEMENT
BY AND BETWEEN
MEDIGROUP OF NEW JERSEY, INC.
AND
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
RELATING TO THE PURCHASE OF
THE HMO AND PPO OPERATIONS OF PHPNJ
---------------------------
DATED AS OF JUNE 26, 1997
---------------------------
<PAGE>
TABLE OF CONTENTS
<TABLE>
<S> <C>
ARTICLE 1.
ASSIGNMENT AND TRANSFER..................................................................................1
Section 1.1 Assignment and Transfer................................................................1
Section 1.2 Excluded Liabilities...................................................................2
Section 1.3 Deposit................................................................................2
Section 1.4 Management Agreement...................................................................3
Section 1.6 Purchase Price Adjustment..............................................................3
Section 1.7 Closing................................................................................3
Section 1.8 Consents to Assignments................................................................5
Section 1.9 Payment of Premiums and Claims.........................................................6
ARTICLE 2.
REPRESENTATIONS AND WARRANTIES...........................................................................6
Section 2.1 Organization, Qualifications and Corporate Power and Business..........................6
Section 2.2 Validity...............................................................................6
Section 2.3 No Conflict............................................................................6
Section 2.4 Contracts..............................................................................7
Section 2.5 Tax Matters............................................................................7
Section 2.6 Litigation; Compliance with Law; Business Practices....................................7
Section 2.7 Other Agreements.......................................................................8
Section 2.8 Defaults...............................................................................8
Section 2.9 Transaction With Affiliates............................................................8
Section 2.10 Governmental Approvals.................................................................8
Section 2.11 Brokers................................................................................9
Section 2.12 Disclosure.............................................................................9
ARTICLE 3.
REPRESENTATIONS AND WARRANTIES OF THE PURCHASER, MEDIGROUP
AND BCBSNJ...............................................................................................9
Section 3.1 Organization, Qualifications and Power and Business....................................9
Section 3.2 Validity...............................................................................9
Section 3.3 No Conflict............................................................................9
Section 3.4 Copies of Contracts...................................................................10
Section 3.5 Brokers...............................................................................10
Section 3.6 Management of the Business............................................................10
Section 3.7 Accuracy of the Seller's Representations..............................................10
Section 3.8 Disclosure............................................................................10
ARTICLE 4.
COVENANTS...............................................................................................10
</TABLE>
i
<PAGE>
<TABLE>
<S> <C>
Section 4.1 Conduct of Business...................................................................10
Section 4.2 Confidentiality.......................................................................11
Section 4.3 Best Efforts..........................................................................12
Section 4.4 Certain Notifications.................................................................12
Section 4.5 Supplemental Disclosure...............................................................12
Section 4.6 Cooperation...........................................................................12
Section 4.7 HMO Endorsement.......................................................................12
Section 4.8 Foundation Support/Recognition........................................................12
Section 4.9 Covenant Not to Compete; Use of Trade Name............................................13
Section 4.10 Board Appointments....................................................................13
Section 4.11 Certificate of Authority..............................................................14
Section 4.12 Non-Solicitation......................................................................14
ARTICLE 5.
CONDITIONS PRECEDENT TO PURCHASER'S OBLIGATIONS.........................................................14
Section 5.1 Representations and Warranties........................................................14
Section 5.2 Covenants and Obligations.............................................................14
Section 5.3 Consents..............................................................................15
Section 5.4 No Proceeding or Litigation...........................................................15
Section 5.5 Closing Deliveries....................................................................15
ARTICLE 6.
CONDITIONS PRECEDENT TO SELLER'S OBLIGATIONS............................................................15
Section 6.1 Representations and Warranties of the Purchaser.......................................15
Section 6.2 Covenants and Obligations of the Purchaser............................................16
Section 6.3 Consents..............................................................................16
Section 6.4 No Proceeding or Litigation...........................................................16
Section 6.5 Closing Deliveries....................................................................16
ARTICLE 7.
INDEMNIFICATION.........................................................................................16
Section 7.1 Indemnification by the Seller.........................................................16
Section 7.2 Indemnification by the Purchaser......................................................17
Section 7.3 General Indemnification Provisions....................................................17
Section 7.4 Limit on Indemnification..............................................................18
ARTICLE 8.
TERMINATION.............................................................................................18
Section 8.1 Termination of Agreement..............................................................18
Section 8.2 Procedure and Effect of Termination...................................................19
ARTICLE 9.
MISCELLANEOUS...........................................................................................20
</TABLE>
ii
<PAGE>
<TABLE>
<S> <C>
Section 9.1 Expenses; Taxes.......................................................................20
Section 9.2 Consents..............................................................................20
Section 9.3 Waiver................................................................................20
Section 9.4 Further Assurances....................................................................20
Section 9.5 Entire Agreement......................................................................20
Section 9.6 Amendment.............................................................................20
Section 9.7 Headings..............................................................................20
Section 9.8 Notices...............................................................................20
Section 9.9 Counterparts..........................................................................21
Section 9.10 Public Announcements..................................................................22
Section 9.11 Construction..........................................................................22
Section 9.12 Recitals..............................................................................22
Section 9.13 Severability..........................................................................22
Section 9.14 Assignment............................................................................22
Section 9.15 Governing Law.........................................................................22
EXHIBIT 1 Contracts
EXHIBIT 2 Management Services Agreement
EXHIBIT 3 Assignment and Assumption Agreement
SCHEDULE I Disclosure Schedule
</TABLE>
iii
<PAGE>
AGREEMENT
THIS AGREEMENT (this "Agreement") is made as of the 26th day of June,
1997, by and between MEDIGROUP OF NEW JERSEY, INC., a New Jersey corporation
(the "Purchaser") , and PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC., a New
Jersey corporation (the "Seller"). MEDIGROUP, INC., a New Jersey corporation
("Medigroup") and BLUE CROSS AND BLUE SHIELD OF NEW JERSEY, INC., a New Jersey
corporation ("BCBSNJ"), are parties to this Agreement for purposes of Sections
1.7(c), 4.6, 4.8, 4.9, 4.10, 6.1, 6.2, 6.5 and of Articles III, VII and IX
hereof.
RECITALS
--------
The Seller is engaged in the business (the "Business") of operating a
statewide, physician- owned health maintenance organization in the State of New
Jersey known as the "Physician Healthcare Plan of New Jersey" (the "Plan"). The
Purchaser is a wholly owned subsidiary of Medigroup, which in turn is a wholly
owned subsidiary of BCBSNJ. The Purchaser operates a health maintenance
organization in the State of New Jersey known as "HMO Blue". On the terms and
subject to the conditions set forth in this Agreement, the Seller desires to
assign and transfer to the Purchaser, and the Purchaser desires to acquire and
assume from the Seller, all right, title and interest of the Seller in and to,
and all duties and obligations of the Seller arising after the Closing Date (as
defined below) with respect to, those group contracts and provider agreements
listed on Exhibit 1 attached hereto and made a part hereof (the "Contracts").
NOW, THEREFORE, in consideration of the premises and other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties agree as follows:
ARTICLE 1.
ASSIGNMENT AND TRANSFER
Section 1.1 Assignment and Transfer.
------------------------
(a) Subject to Section 1.1(B) below and the other terms and conditions
contained herein, on the Closing Date, the Seller, for and in consideration of
the Purchase Price (as defined below) and the assumption and performance by the
Purchaser of the Seller's duties, obligations and liabilities under the
Contracts arising from and after the Closing Date, does hereby irrevocably and
unconditionally assign and transfer unto the Purchaser all of the Seller's
right, title and interest in and to each of the Contracts and all the duties,
obligations and liabilities of the Seller under or relating to the Contracts to
the extent accruing or arising on or after the Closing Date (but not
attributable to the period prior to the Closing Date); provided, that nothing
herein shall be construed as an assignment, transfer, sale, delegation, setting
over or assumption of any duty, obligation or liability
<PAGE>
of the Seller under or relating to the Contracts to the extent arising or
accruing (whether or not asserted or assessed) prior to the Closing Date.
(b) From and after the Closing Date, the Purchaser acquires and assumes
each of the Contracts and agrees to satisfy, discharge and perform all of the
duties, obligations and liabilities of the Seller under or relating to the
Contracts to the extent accruing or arising on or after the Closing Date (but
not attributable to the period prior to the Closing Date).
(c) Notwithstanding anything herein to the contrary, the Seller shall
retain and is not hereby selling, assigning or otherwise transferring any of the
following assets and property:
(i) cash on hand, cash equivalents, investments (including
stock, debt instruments, options and other instruments and securities) and bank
deposits;
(ii) all accounts, premiums or other amounts due to the Seller
for the period up to and including the Closing Date;
(iii) tax refunds, tax, insurance and other claims or rights
to recoveries and similar benefits of the Business and any prepaid items with
respect to the Business prior to the Closing Date; and
(iv) all other assets of the Seller not included among the
Contracts.
Section 1.2 Excluded Liabilities. The Purchaser shall not be required to assume,
perform or otherwise discharge any liabilities or obligations arising out of,
relating to, or in connection with, any shareholder of the Seller or the
operation of the Business prior to the Closing Date (the "Excluded
Liabilities"), including, without limitation, any liability or obligation
arising prior to the Closing Date (a) under the Contracts or any agreements
other than the Contracts to which the Seller is a party or by which it is bound;
(b) for Federal, state or local income taxes, personal property, excise, sales
or franchise taxes relating to or arising out of the operation of the Business;
and (c) for incurred but not reported claims relating to or arising out of the
operation of the Business.
Section 1.3 Deposit. In consideration for the Seller entering in that certain
Letter of Intent dated June 11, 1997, with the Purchaser, Medigroup and BCBSNJ
(the "Letter of Intent"), the Purchaser has made a good faith deposit of
$500,000.00 (the "Deposit") with Mellon Bank, N.A., as escrow agent ("Mellon").
Subject to the terms of that certain Escrow Agreement among the Seller, the
Purchaser and Mellon dated June 13, 1997, the parties agree that (a) if the
shareholders of the Seller disapprove or the Regulatory Agencies (as defined
below) disapprove the transactions contemplated hereby, Mellon shall return the
Deposit with all interest thereon to the Purchaser; and (b) if the shareholders
of the Seller and the Regulatory Agencies approve the transactions contemplated
hereby, Mellon shall disburse the Deposit and all interest thereon to the
Seller, and the Purchaser shall be entitled to a credit in accordance with
Section 1.6 below.
2
<PAGE>
Section 1.4 Management Agreement. Prior to or contemporaneously with the
approval by the Seller's Board of Directors of this Agreement for referral to
the Seller's shareholders for approval, the Seller and the Purchaser, as
manager, will enter into a Management Services Agreement (the "Management
Agreement") in the form of Exhibit 2 attached hereto and made a part hereof.
Pursuant to the terms of the Management Agreement, the Purchaser will provide
the Seller for the term set forth in the Management Agreement with all
management and administrative services necessary for the operation of the
Business, including, but not limited to, claims processing, member services,
enrollment, provider assistance, utilization management and financial services,
including accounting and reporting, for all product lines of the Seller;
provided, however, that such services shall not include any reporting to the
Securities Exchange Commission or any related Federal and state reporting
required under the securities laws of the United States or of the State of New
Jersey.
Section 1.5 Purchase Price; Payment. Subject to adjustment pursuant to Section
1.6 below, the purchase price (the "Purchase Price") for the assignment and
transfer of the Contracts shall be an amount equal to the sum of: (a) the
greater of One Million Dollars ($1,000,000.00) or Three Hundred Dollars
($300.00) per health maintenance organization member certified by the Purchaser,
as manager, to be enrolled in the Plan as of the Closing Date (the total of such
members being the "Certified Number"), payable to the Seller at the Closing (as
defined below) by wire transfer of immediately available funds to an account
designated by the Seller; and (b) Ten Dollars ($10.00) for each eligible Health
Care Payers Coalition ("HCPC") life to whom the services of the Purchaser are
available on the first anniversary of the Closing Date, payable to the Seller on
that date by wire transfer of immediately available funds to an account
designated by the Seller.
Section 1.6 Purchase Price Adjustment. The Purchaser shall be entitled to a
credit against the Purchase Price at Closing in a sum equal to the amount of the
Deposit actually received by the Seller. In addition, the Purchase Price may be
adjusted as follows: thirty (30) days after the Closing Date, the Seller, at its
sole cost, may verify, by independent audit, the number of health maintenance
organization members enrolled in the Plan as of the Closing Date and, if the
Seller has elected to verify such number by audit, shall notify the Purchaser of
such number in writing. If such number is higher than the Certified Number, the
Purchaser shall pay to the Seller an amount equal to Three Hundred Dollars
($300.00) per each additional member in the Plan. If such number is lower than
the Certified Number, the Seller shall rebate to the Purchaser from the Purchase
Price an amount equal to Three Hundred Dollars ($300.00) times such difference;
provided, however, that in no event will any such rebate reduce the Purchase
Price below $1,000,000.00. In each case, the applicable payment shall be made
within three (3) business days after such notice from the Seller.
Section 1.7 Closing.
-------
(a) Subject to the terms and conditions of this Agreement, the closing
on the assignment and transfer of the Contracts contemplated hereby (the
"Closing") shall take place on a date (the "Closing Date") within ten (10)
business days after the receipt of the Material Consents (as defined below) at
such time and place as the Seller and the Purchaser may mutually agree in
writing; provided, however, that, prior to the Closing, all of the conditions
set forth in Articles V and VI of
3
<PAGE>
this Agreement shall have been satisfied or waived in writing by the party
entitled to claim the benefit thereof.
(b) At the Closing, the Seller shall deliver, or cause to be delivered,
to the Purchaser the following (collectively, the "Seller Closing Deliveries"):
(i) a copy of the resolutions of the Board of Directors of the
Seller, certified by its Secretary, authorizing, subject to the approval of the
shareholders of the Seller, the execution, delivery and performance of this
Agreement and the other instruments and documents required to be executed and
delivered by it in connection herewith (collectively, the "Seller Related
Documents") and, subject to the approval of the Seller's shareholders,
authorizing the assignment and transfer contemplated hereby and thereby (the
"Transaction");
(ii) a copy of the minutes of the meeting of the shareholders
of the Seller, certified by the Secretary of the Seller, authorizing the
execution, delivery and performance of this Agreement and the other Seller
Related Documents and the consummation of the Transaction;
(iii) evidence of all required governmental and regulatory
approvals, including, without limitation, any approvals (the "Material
Consents") of the Commissioner of Health and Senior Services and the
Commissioner of Banking and Insurance of the State of New Jersey (collectively,
the "Regulatory Agencies"), required in connection with: (A) the execution and
delivery of this Agreement and the other Seller Related Documents; (B) the
consummation of the Transaction; and (C) the assignment and transfer to the
Purchaser of the Contracts; in each case in form reasonably satisfactory to the
Purchaser (collectively, the "Regulatory Approvals");
(iv) the assignment by the Seller to the Purchaser of all of
the Seller's right, title and interest in the Contracts, and the assumption by
the Purchaser of all of the Seller's liabilities arising after Closing under the
Contracts in accordance with the terms of an Assignment and Assumption Agreement
substantially in the form of Exhibit 3 attached hereto and made a part hereof;
(v) the certificate referred to in Section 5.1 below; and
(vi) copies of the Certificate of Incorporation and all
amendments thereto, as recorded, and the corporate by-laws and all amendments
thereto, of Seller, certified by its Secretary; and a good standing certificate
of the Seller dated no earlier than twenty (20) days prior to the Closing Date.
(c) At the Closing, the Purchaser, Medigroup and BCBSNJ shall deliver
to the Seller all of the following (collectively, the "Purchaser Closing
Deliveries"):
(i) the Purchase Price in the manner set forth above;
(ii) copies of resolutions of the Boards of Directors of
each of the Purchaser,
4
<PAGE>
Medigroup and BCBSNJ, certified by their respective secretaries or other
authorized representatives, authorizing the execution, delivery and performance
of this Agreement and the other instruments and documents required to be
executed and delivered by any of the Purchaser, Medigroup and BCBSNJ in
connection herewith (collectively, the "Purchaser Related Documents") and
authorizing the consummation of the Transaction;
(iii) evidence of the appointment by BCBSNJ of two (2)
physicians selected by the Seller or the Foundation (as defined below) to
BCBSNJ's Medical Policy Committee and of one (1) physician selected by the
Seller or the Foundation to BCBSNJ's Professional Advisory Committee;
(iv) evidence of the appointment by the Purchaser of two (2)
physicians selected by the Seller or the Foundation to the Purchaser's Quality
Improvement Committee and of two (2) physicians selected by the Seller or the
Foundation to such committee's subcommittees on Clinical Issues, Credentialing
and Grievance/Appeals;
(v) evidence of the appointment by the Purchaser to its Panel
of Independent Medical Examiners of two (2) physicians selected by the Seller or
the Foundation (meeting the Purchaser's applicable credentialing requirements)
for each specialty represented on such panel;
(vi) evidence of the appointment by Medigroup's shareholder of
one (1) physician selected from a slate of at least three (3) physicians
presented by the Seller or the Foundation to the Board of Directors of Medigroup
for a minimum term of three (3) years;
(vii) the certificate referred to in Section 6.1 below;
(viii) copies of the Certificate of Incorporation and all
amendments thereto, as recorded, and the corporate by-laws and all amendments
thereto, of each of the Purchaser, Medigroup and BCBSNJ, certified by their
respective Secretaries; and a good standing certificate of each of the
Purchaser, Medigroup and BCBSNJ dated no earlier than twenty (20) days prior to
the Closing Date;
(ix) a certificate of the Purchaser, as manager, certifying
the number of health maintenance organization members enrolled in the Plan as of
the Closing Date; and
(x) a proposal from the Purchaser regarding a product to be
offered by Princeton Medical Management, LLC ("Princeton") that, in the
reasonable determination of the Purchaser and the Seller, is generally
consistent with the type of product intended to be offered by Princeton, or
which constitutes a satisfactory alternative product.
Section 1.8 Consents to Assignments. The Seller shall use its best efforts to
obtain the consent of Bayonne Hospital to the assignment to the Purchaser of
that certain Hospital Participation Agreement dated September 16, 1996, between
the Seller and Bayonne Hospital.
5
<PAGE>
Section 1.9 Payment of Premiums and Claims. The Seller and the Purchaser agree
that to the extent the Purchaser receives from and after the Closing Date
premiums payable under any of the Contracts for the period prior to the Closing
Date, the Purchaser will promptly pay to the Seller all such premiums on a
weekly basis. To the extent the Purchaser properly pays from and after the
Closing Date any claims incurred prior to the Closing Date, the Seller shall
reimburse the Purchaser within one (1) business day after the Seller's receipt
of the Purchaser's invoice for such payments, provided said invoice contains
information on the claims comparable to the information contained on the HCFA
1500 form or UB-92 form, as applicable. The Purchaser shall submit its invoice
no more frequently than once weekly. The invoice shall be in such form and
detail as the Seller may reasonably require. All reimbursements by the Seller
pursuant to this Section shall be subject to subsequent audit and verification,
and for such purposes, the Purchaser agrees to provide the Seller and its
accountants, agents and representatives reasonable access during normal business
hours to the Purchaser's books and records relating to the payment of such
claims. This Section shall survive Closing.
ARTICLE 2.
REPRESENTATIONS AND WARRANTIES
OF THE SELLER
The Seller hereby makes to the Purchaser the representations and
warranties set forth in this Article II. Exceptions to the representations and
warranties made in this Article II are as set forth in the Disclosure Schedule
attached hereto as Schedule I ("Schedule I").
Section 2.1 Organization, Qualifications and Corporate Power and Business. The
Seller is a corporation duly organized, validly existing and in good standing
under the laws of the State of New Jersey. The Seller has the corporate power
and authority to own and hold its properties in order to carry on the Business
as it is now being conducted and to execute, deliver and perform this Agreement
and the other Seller Related Documents.
Section 2.2 Validity. This Agreement and the other Seller Related Documents have
been duly executed and delivered by the Seller, and, assuming their due
execution and delivery by the Purchaser, Medigroup and BCBSNJ (as applicable),
constitute the legal, valid and binding obligations of the Seller, enforceable
in accordance with their respective terms, except to the extent such
enforceability may be limited by applicable laws affecting the enforcement of a
party's rights generally and by principles of equity regarding the availability
of remedies.
Section 2.3 No Conflict. The execution, delivery and performance by the Seller
of this Agreement and the other Seller Related Documents (a) do not violate any
provision of applicable laws, any order of any court or other agency of
government, the charter or by-laws of the Seller, or any provision of any
indenture, agreement or other instrument to which the Seller or any of its
properties or assets is bound, and (b) do not conflict with or constitute (with
due notice or lapse of time or both) a default that would allow the other party
to accelerate the obligations of the Seller due such party or
6
<PAGE>
otherwise exercise rights against the Seller under any such indenture, agreement
or other instrument, or result in the creation or imposition of any lien,
charge, restriction, claim or encumbrance of any nature whatsoever upon any of
the properties or assets of the Seller, including, without limitation, the
Contracts.
Section 2.4 Contracts. Assuming the due execution and delivery of the Contracts
by the other parties thereto, the Contracts constitute the legal, valid and
binding obligations of the Seller, enforceable in accordance with their
respective terms, except to the extent such enforceability may be limited by
applicable laws affecting the enforcement of a party's rights generally and by
principles of equity regarding the availability of remedies. To the knowledge of
the Seller, the Contracts are in full force and effect, and except as set forth
in Schedule I hereto, neither the Seller nor any party thereto has provided
notice, nor does the Seller have any knowledge of any intent to provide notice,
or an election to exercise any rights to terminate any of the Contracts. Other
than the Contracts and except as set forth in Schedule I hereto, there are no
other agreements between the Seller and any insurance company, health
maintenance organization or other third party payor for medical services
rendered or to be rendered by the Seller to patients served thereby, whether
such agreement be in the form of a capitation plan or otherwise.
Section 2.5 Tax Matters.
-----------
(a) The Seller has filed or will file when due all Federal, state, and
local income tax returns and reports in all requisite jurisdictions for all
years and periods ended on or before the Closing Date. For purposes of this
Agreement, "Taxes" means all income, capital gains, gross income, gross
receipts, transfer, value added, sales, use, service, ad valorem, franchise,
profits, capital stock, license, withholding, payroll, employment, social
security, unemployment compensation, utility, excise, production, severance,
stamp, occupation, premium, real or personal property, alternative minimum,
environmental, or windfall profit taxes, customs, duties, or other taxes, fees,
assessments, levies, imposts or charges of any kind whatsoever imposed by any
governmental authority (a "Taxing Authority") responsible for the imposition of
any such Tax, together with any interest and any penalties, additions to tax or
additional amounts imposed by any Taxing Authority.
(b) There are no claims or investigations by any Taxing Authority
pending or, to the knowledge of the Seller, threatened against the Seller, and
the Seller has not received any notice of any threatened claims or
investigations by any Taxing Authority; and, with respect to any Tax return
filed by the Seller, there has been no waiver of any applicable statute of
limitations or extension of the time for the assessment of any Tax against the
Seller.
Section 2.6 Litigation; Compliance with Law; Business Practices.
---------------------------------------------------
(a) There is no (i) action, suit, claim, proceeding or investigation
pending or, to the knowledge of the Seller, threatened against or affecting the
Business, at law or in equity, or before or by any Federal, state, municipal or
other governmental department, commission, board, bureau, agency or
instrumentality, domestic or foreign, including malpractice claims; (ii)
arbitration
7
<PAGE>
proceeding involving the Business pending under any collective bargaining
agreement or otherwise; or (iii) governmental inquiry pending or, to the
knowledge of the Seller, threatened against or affecting the Business
(collectively, "Litigation Matters"). Schedule I hereto contains a list of all
Litigation Matters to which the Seller has been a party as it relates to the
Business during the two (2) years immediately preceding the Closing. The Seller
has not received any opinion or memorandum or legal advice from legal counsel to
the effect that it is exposed, from a legal standpoint, to any liability or
disadvantage that may have a material adverse affect on the Business. The Seller
is not in default with respect to any order, writ, injunction or decree known to
or served upon the Seller of any court or of any Federal, state, municipal or
other governmental department, commission, board, bureau, agency or
instrumentality, domestic or foreign, as it relates to the Business.
(b) The Seller (i) has complied in all material respects with all laws,
rules, regulations and orders that are applicable to the Business, and (ii) has
obtained all necessary permits, licenses and other authorizations required to
enable it to conduct the Business as it is now being conducted. There is no
existing law, rule, regulation or order, whether Federal or state or local, that
would prohibit or restrict the Seller from operating the Business as it is now
being operated.
Section 2.7 Other Agreements. The Seller is not a party to or otherwise bound by
any written or oral agreement or instrument or other restriction that
individually or in the aggregate will materially adversely affect the Business.
Section 2.8 Defaults. With respect to the Business, the Seller has performed all
the obligations required to be performed by it to date, has received no notice
of default and is not in default, in any respect (with due notice or lapse of
time or both) under any agreement now in effect, the result of which could
materially adversely affect the Business. The Seller has no present expectation
or intention of not fully performing all its obligations under each such
agreement in all respects, and the Seller does not have any knowledge of any
breach and has not received any written notice of any anticipated breach by the
other party to any agreement to which the Seller is a party and that pertains to
the Business.
Section 2.9 Transaction With Affiliates. Except as set forth on Schedule I
hereto, no director, officer or stockholder of the Seller, or member of the
family of any such person, or any corporation, partnership, trust or other
entity in which any such person, or any member of the family of any such person,
has a substantial interest or is an officer, director, trustee, partner or
holder of more than 5% of the outstanding capital stock thereof or is presently
or contemplated to be a party to any transaction with the Seller relating to the
Business, including any contract, agreement or other arrangement providing for
the employment of, furnishing of services by, rental of real or personal
property from or otherwise requiring payments to any such person or firm.
Section 2.10 Governmental Approvals. Except for the Regulatory Approvals, no
registration or filing with, or consent or approval of or other action by, any
Federal, state or other governmental agency or instrumentality is or will be
necessary for the valid execution, delivery and performance by
8
<PAGE>
the Seller of this Agreement or any of the other Seller Related Documents, or
the conduct of the Business in the manner in which the Business has been
conducted.
Section 2.11 Brokers. Except with respect to the engagement of Shattuck Hammond
Partners, Inc. by the Seller, for which the Seller shall be solely responsible,
there exists no contract, arrangement or understanding between the Seller and a
broker, finder or similar agent with respect to the Transaction.
Section 2.12 Disclosure. This Agreement and the other Seller Related Documents,
contain no untrue statement of a material fact or omit to state a material fact
necessary to make the statements contained herein not misleading. None of the
written statements, documents, certificates or other written materials prepared
or supplied by the Seller with respect to the Transaction, when read together
and in light of the circumstances in which they were made, contain an untrue
statement of a material fact or omit to state a material fact necessary to make
the statements contained therein not misleading.
ARTICLE 3.
REPRESENTATIONS AND WARRANTIES OF THE PURCHASER, MEDIGROUP
AND BCBSNJ
Each of the Purchaser, Medigroup and BCBSNJ represents and warrants to
the Seller as follows:
Section 3.1 Organization, Qualifications and Power and Business. Each of the
Purchaser, Medigroup and BCBSNJ is a corporation duly organized, validly
existing and in good standing under the laws of the State of New Jersey. Each of
the Purchaser, Medigroup and BCBSNJ has the power and authority to own and hold
its properties and to carry on its business as it now being conducted and as
proposed to be conducted and to execute, deliver and perform this Agreement and
the other Purchaser Related Documents.
Section 3.2 Validity. This Agreement and the other Purchaser Related Documents
have been duly executed and delivered by Purchaser, Medigroup and/or BCBSNJ (as
applicable) and, assuming the due execution and delivery by the Seller,
constitute the legal, valid and binding obligations of the Purchaser, Medigroup
and BCBSNJ (as applicable), enforceable in accordance with their respective
terms, except to the extent such enforceability may be limited by applicable
laws affecting the enforcement of a party's rights generally and by principles
of equity regarding the availability of remedies.
Section 3.3 No Conflict. The execution, delivery and performance by the
Purchaser, Medigroup and BCBSNJ of this Agreement and the other Purchaser
Related Documents (a) do not violate any provision of applicable law, any order
of any court or other agency of government, the charters or by-laws of the
Purchaser, Medigroup and BCBSNJ, or any provision of any indenture, agreement or
9
<PAGE>
other instrument to which any of the Purchaser, Medigroup and BCBSNJ or any of
its properties or assets is bound, and (b) do not conflict with or constitute
(with due notice or lapse of time or both) a default that would allow the other
party to accelerate the obligations of any of the Purchaser, Medigroup and
BCBSNJ due such party or otherwise exercise rights against any of the Purchaser,
Medigroup and BCBSNJ under any such indenture, agreement or other instrument, or
result in the creation or imposition of any lien, charge, restriction, claim or
encumbrance of any nature whatsoever upon any of the properties or assets of the
Purchaser, Medigroup or BCBSNJ.
Section 3.4 Copies of Contracts. The Purchaser acknowledges receipt of copies of
all of the Contracts (other than the physician participation agreements).
Section 3.5 Brokers. None of the Purchaser, Medigroup or BCBSNJ has any
contract, arrangement or understanding with any broker, finder or similar agent
with respect to the Transaction.
Section 3.6 Management of the Business. In its management of the Business
pursuant to the Management Agreement, the Purchaser, as manager, will not take
any action or fail to take any action that is likely to cause any of the
representations and warranties of the Seller set forth herein to become false or
misleading in any way. The Purchaser acknowledges the Seller's objective of
retaining as many health maintenance organization members as possible during the
term of the Management Agreement.
Section 3.7 Accuracy of the Seller's Representations. To the best knowledge of
the Purchaser, Medigroup and BCBSNJ, this Agreement contains no untrue statement
of a material fact and do not omit to state a material fact necessary to make
the statements contained herein not misleading.
Section 3.8 Disclosure. This Agreement and the other Purchaser Related Documents
contain no untrue statement of a material fact or omit to state a material fact
necessary to make the statements contained herein not misleading. None of the
written statements, documents, certificates or other written materials prepared
or supplied by the Purchaser, Medigroup or BCBSNJ with respect to the
Transaction, when read together and in light of the circumstances in which they
were made, contain an untrue statement of a material fact or omit to state a
material fact necessary to make the statements contained therein not misleading.
ARTICLE 4.
COVENANTS
Section 4.1 Conduct of Business.
-------------------
(a) Between the date hereof and the Closing Date, without the consent
of the Seller, the Purchaser, as manager, shall not, and the Seller shall not
itself nor cause the Purchaser, as manager, to:
10
<PAGE>
(i) conduct the Business other than in the ordinary course,
except that the Seller may choose not to engage in active selling of its product
line;
(ii) make any sale, assignment, transfer or other disposition
of any Contract or mortgage, pledge or otherwise create a security interest in
any of the Contracts;
(iii) modify, extend, renew or terminate any of the Contracts
(other than the routine renewals of the Contracts) or enter into any commitment
or agreement similar to the Contracts;
(iv) fail to maintain the books, accounts and records of the
Business on a basis consistent with past practice;
(v) create, incur or assume any indebtedness (except for
accounts payable in the ordinary course of business) for money borrowed in
connection with the operation of the Business;
(vi) with respect to the Business, effect any transaction with
any other entity or person, the terms of which are not commercially reasonable
or are other than on an arm's length basis;
(vii) undertake any action or engage in any omission that
shall impair or jeopardize the Seller's rights to any of the Contracts; or
(viii) enter into any agreement, commitment or arrangement
with respect to any of the actions prohibited by the foregoing.
(b) From the date hereof until the Closing Date, the Purchaser, as
manager, shall not, and the Seller shall not cause the Purchaser, as manager, to
take any action that would cause any of the representations and warranties made
in Article II hereof not to remain true and correct.
(c) From the date hereof until the Closing Date, the Seller shall keep
the Purchaser advised of any significant decisions concerning the Business.
(d) From the date hereof until the Closing Date, the Seller and the
Purchaser, as manager, shall take such steps in the ordinary course of business
as are reasonable to retain the Seller's existing relationships with providers,
subscribers and third party payors.
Section 4.2 Confidentiality. Except as required by law, no party hereto, nor
their respective successors, assigns, affiliates, directors, officers,
representatives, agents or employees, shall disclose or use any confidential
information received hereunder or provided by any party to the other, except in
connection with the consummation of the Transaction. If this Agreement
terminates without the consummation of the Transaction, the parties shall (a)
hold in confidence and refrain from using all non-public information received in
connection with the Transaction; and (b) promptly return to the party supplying
such confidential information any confidential information, including, without
limitation, the Letter of Intent, and all copies in its possession or in the
possession of its
11
<PAGE>
representatives of such confidential information, or destroy such information
and certify its destruction in writing. If, pursuant to a court or other legal
order, any party, (the "Requested Party") is requested or required (by oral
questions, interrogatories, requests for information or documents, subpoena,
civil investigative demand or similar process) to disclose any information
supplied to it, its directors, officers, employees, representatives or agents in
the course of its dealings hereunder, on the subject matter hereof, the parties
agree that the Requested Party will provide the other parties with prompt
written notice of such request or requirement so that the other parties may seek
an appropriate protective order and/or waive the Requested Party's compliance
with the provisions of this Agreement; but it is understood that the Requested
Party will be obligated to, and may comply with, requirements of law.
Section 4.3 Best Efforts. Each party hereto shall use its best efforts to
fulfill its conditions to Closing and otherwise to consummate the Transaction.
Section 4.4 Certain Notifications. At all times prior to the Closing, each party
hereto shall, as promptly as reasonably practicable, notify the other in writing
of the occurrence of any event as to which it obtains knowledge that is
reasonably likely to result in the failure of a condition precedent to Closing
contained in Article V or Article VI below. The party receiving such notice
shall have the right, but not the obligation, for a period of three (3) business
days, to attempt to cure the anticipated failure of the condition precedent. The
Seller and the Purchaser, as manager, promptly shall notify the other of the
occurrence of a material adverse change in the Business or of any termination,
non-renewal or material alteration of any Contract.
Section 4.5 Supplemental Disclosure. Each of the parties hereto shall have the
continuing obligation to promptly supplement or amend this Agreement with
respect to any matter hereafter arising or discovered that, if existing or known
at the date of this Agreement, would have been required to be set forth or
described herein; provided, however, that for the purpose of the rights and
obligations of the parties hereunder, any such supplemental or amended
disclosure shall not be deemed to have been disclosed as of the date of this
Agreement unless so agreed to in writing by the party making the disclosure,
and, accordingly, shall have no effect on the liabilities or obligations of the
parties under this Agreement.
Section 4.6 Cooperation. The parties agree to cooperate fully with one another
to effect the transfer of the Contracts, to meet with the Regulatory Agencies to
facilitate the consummation of the Transaction and to prepare and file all
necessary filings promptly to obtain the Material Consents and to respond as
otherwise requested by the Regulatory Agencies. No party shall meet separately
with any of the Regulatory Agencies regarding the Transaction unless required to
do so by the Regulatory Agencies or agreed to by the other party.
Section 4.7 HMO Endorsement. The Seller agrees to explore with the Purchaser a
mutually acceptable form of endorsement by the Seller of the Purchaser for the
period of time after Closing that the Seller maintains its Certificate of
Authority in the State of New Jersey.
12
<PAGE>
Section 4.8 Foundation Support/Recognition. The Purchaser, Medigroup and BCBSNJ
acknowledge and agree that the Seller may establish a successor entity, which
may be a private tax-exempt foundation under Section 509(a) of the Code (the
"Foundation") to, among other things, carry on the Seller's mission of advancing
the interest of physician-directed medical services and to select the physicians
for the board, committees and medical panels described in Section 4.10 below if
the Seller itself does not make that selection. If so requested by the
Purchaser, marketing and promotional materials for Foundation programs that are
financially supported by the Purchaser, Medigroup and/or BCBSNJ would carry the
notation that the program is "sponsored in part by HMO Blue", Medigroup or
BCBSNJ. The Purchaser, Medigroup and BCBSNJ acknowledge and agree that a private
foundation such as the Foundation may not endorse a for-profit operation.
Section 4.9 Covenant Not to Compete; Use of Trade Name. For no additional
consideration, for a period of one (1) year after the Closing Date, neither the
Seller nor any entity in which the Seller is a majority owner (an "Affiliate")
will, directly or indirectly, engage in the business of providing or arranging
for the provision of managed health care insurance (including HMO, PPO, POS and
ASO arrangements) in the State of New Jersey. In addition, for a period of five
(5) years following the surrender of the Seller's Certificate of Authority to
the State of New Jersey, the Seller and its Affiliates will not use any name,
trade name, trademark, brand name or service mark, including, without
limitation, "Physician Healthcare Plan of New Jersey," that is confusingly
similar to those used by the Seller or its Affiliates as of the Closing Date.
Notwithstanding this, the Purchaser, Medigroup and BCBSNJ acknowledge and agree
that the use by the Foundation of any name, trade name, trademark, brand name or
service mark, including, without limitation, "Physician Healthcare Plan of New
Jersey," that is similar to those used by the Seller or its Affiliates as of the
Closing Date shall not be a violation of this Section.
Section 4.10 Board Appointments. This Section shall survive Closing.
------------------
(a) Prior to or effective with Closing, BCBSNJ shall appoint two (2)
physicians selected by the Seller or the Foundation to BCBSNJ's Medical Policy
Committee and one (1) physician selected by the Seller or the Foundation to
BCBSNJ's Professional Advisory Committee. BCBSNJ agrees that the Seller and/or
the Foundation shall be entitled to this physician representation on said
committees (or any successor committees) for at least five (5) years.
(b) Prior to or effective with Closing, the Purchaser shall appoint two
(2) physicians selected by the Seller or the Foundation to the Purchaser's
Quality Improvement Committee and two (2) physicians selected by the Seller or
the Foundation to such committee's subcommittees on Clinical Issues,
Credentialing and Grievance/Appeals. The Purchaser agrees that the Seller and/or
the Foundation shall be entitled to this physician representation on said
committee and subcommittees (or any successor committees or subcommittees) for
at least five (5) years.
(c) Prior to or effective with Closing, the Purchaser shall appoint to
its Panel of Independent Medical Examiners two (2) physicians selected by the
Seller or the Foundation (meeting the Purchaser's applicable credentialing
requirements) for each specialty represented on such panel.
13
<PAGE>
The Purchaser agrees that the Seller and/or the Foundation shall be entitled to
this physician representation on said panel (or any successor panels) for at
least five (5) years.
(d) Prior to or effective with Closing, Medigroup agrees that its
shareholder shall elect one (1) physician selected from a slate of at least
three (3) physicians presented by the Seller or the Foundation to the Board of
Directors of Medigroup for a minimum term of three (3) years.
Section 4.11 Certificate of Authority. After Closing, the Seller shall surrender
its health maintenance organization Certificate of Authority to the State of New
Jersey in accordance with applicable regulatory requirements.
Section 4.12 Non-Solicitation. From the date of this Agreement until the Closing
Date, the Seller shall not, directly or indirectly, through any officer,
director, employee, representative, advisor, agent or otherwise, (a) solicit or
initiate, directly or indirectly, or encourage the submission of inquiries,
proposals or offers from any other potential buyer relating to the disposition
of the Contracts; or (b) respond to any person indicating an interest in
purchasing the Contracts by participating in any discussions or negotiations
regarding, or furnish to any person any information with respect to, the
disposition of the Contracts. If the Seller is presented with an unsolicited
offer to purchase its HMO and PPO operations on terms the Board of Directors of
the Seller considers more favorable than the terms set forth herein, the Seller
shall provide the Purchaser with a right of first opportunity to purchase these
operations on terms equivalent to or better than the terms set forth in the
unsolicited offer. The Purchaser shall exercise its right of first opportunity
within five (5) business days of written notice thereof, or its right shall
automatically expire.
ARTICLE 5.
CONDITIONS PRECEDENT TO PURCHASER'S OBLIGATIONS
Unless waived in writing by the Purchaser in its sole discretion, the
obligations of the Purchaser hereunder shall be subject to the fulfillment,
prior to or at the Closing, of each of the following conditions precedent:
Section 5.1 Representations and Warranties. Each of the representations and
warranties contained in Article II hereof shall be true and accurate in all
respects as of the date of this Agreement and shall be true and accurate in all
respects as of the Closing Date as if made on the Closing Date (except for any
representation or warranty expressly stated to have been made or given as of a
specified date, which, at the Closing Date, shall be true and correct in all
respects as of the date expressly stated and except for any breach after the
date of this Agreement that has been caused by the Purchaser, as manager, in its
management of the Business). This Section shall be deemed satisfied
notwithstanding that some of the agreements comprising the Contracts are not
renewed in the ordinary course of business. The Seller shall have delivered to
the Purchaser a certificate of its Chairman of the Board certifying the
fulfillment of the conditions set forth in this Section 5.1 and in Sections 5.2
and 5.3
14
<PAGE>
below, and a certificate of the Secretary of the Seller, as to the incumbency of
such officer executing the certificate.
Section 5.2 Covenants and Obligations. All of the covenants and obligations that
the Seller is required to perform or to comply with pursuant to the terms of
this Agreement and pursuant to each of the other Seller Related Documents at or
prior to Closing shall have been duly performed or complied with by the Seller
in all material respects prior to the Closing Date.
Section 5.3 Consents. All Regulatory Approvals shall have been obtained, and the
Seller shall have obtained the consent and approval of its Board of Directors
and shareholders to this Agreement, the other Seller Related Documents and the
Transaction.
Section 5.4 No Proceeding or Litigation.
---------------------------
(a) No preliminary or permanent injunction or other order
shall have been issued by any court of competent jurisdiction, whether Federal,
state or foreign, or by any governmental or regulatory body, whether Federal,
state or foreign, nor shall any statute, rule, regulation or executive order be
promulgated or enacted by any governmental authority, whether Federal, state or
foreign, that prevents the consummation of the Transaction.
(b) No suit, action, claim, proceeding or investigation before
any court, arbitrator or administrative, governmental or regulatory body,
whether Federal, state or foreign, shall have been commenced and be pending
against the Seller or any of its affiliates, officers or directors seeking to
prevent the assignment and transfer of the Contracts or asserting that the
assignment and transfer of the Contracts would be illegal.
Section 5.5 Closing Deliveries. On or before the Closing Date, each of the
Seller Closing Deliveries shall have been delivered to the Purchaser, and the
Purchaser and its counsel shall be reasonably satisfied with the form and
substance thereof.
ARTICLE 6.
CONDITIONS PRECEDENT TO SELLER'S OBLIGATIONS
Unless waived in writing by the Seller, in its sole discretion, the
obligations of the Seller hereunder shall be subject to the fulfillment, prior
to or at the Closing, of each of the following conditions precedent:
Section 6.1 Representations and Warranties of the Purchaser. Each of the
representations and warranties of the Purchaser, Medigroup and BCBSNJ contained
in Article III above shall be true and accurate in all respects as of the date
of this Agreement and shall be true and accurate in all respects as of the
Closing Date as if made on the Closing Date (except for any representation or
warranty expressly stated to have been made or given as of a specified date,
which, at the Closing Date, shall
15
<PAGE>
be true and correct in all respects as of the date expressly stated). Each of
the Purchaser, Medigroup and BCBSNJ shall have delivered to the Seller a
certificate of its president or any vice president certifying the fulfillment of
the conditions set forth in this Section 6.1 and in Sections 6.2 and 6.3 below,
and a certificate of the Secretary of each of the Purchaser, Medigroup and
BCBSNJ as to the incumbency of such officer executing the certificate.
Section 6.2 Covenants and Obligations of the Purchaser. All of the covenants and
obligations that any of the Purchaser, Medigroup and BCBSNJ is required to
perform or to comply with pursuant to the terms of this Agreement and each of
the other Purchaser Related Documents at or prior to Closing shall have been
duly performed or complied with by such party in all material respects prior to
the Closing Date.
Section 6.3 Consents. All Regulatory Approvals shall have been obtained, and the
Purchaser, Medigroup and BCBSNJ shall have obtained the consent and approval of
the Boards of Directors of each of the Purchaser, Medigroup and BCBSNJ to this
Agreement, the other Purchaser Related Documents and the Transaction.
Section 6.4 No Proceeding or Litigation.
---------------------------
(a) No preliminary or permanent injunction or other order
shall have been issued by any court of competent jurisdiction, whether Federal,
state or foreign, or by any governmental or regulatory body, whether Federal,
state or foreign, nor shall any statute, rule, regulation or executive order be
promulgated or enacted by any governmental authority, whether Federal, state or
foreign, that prevents the consummation of the Transaction.
(b) No suit, action, claim, proceeding or investigation before
any court, arbitrator or administrative, governmental or regulatory body,
whether Federal, state or foreign, shall have been commenced and be pending
against any of the Purchaser, Medigroup and BCBSNJ or any of their affiliates,
officers or directors seeking to prevent the assignment and transfer of the
Contracts or asserting that the assignment and transfer of the Contracts would
be illegal.
Section 6.5 Closing Deliveries. On or before the Closing Date, the Purchaser,
Medigroup and BCBSNJ shall have delivered to the Seller each of the Purchaser
Closing Deliveries, and the Seller and its counsel shall be reasonably satisfied
with the form and substance thereof.
ARTICLE 7.
INDEMNIFICATION
Section 7.1 Indemnification by the Seller.
-----------------------------
Except as otherwise limited by this Article VII, the Seller shall
indemnify, defend and hold harmless the Purchaser and its officers, directors,
employees, agents, successors and assigns
16
<PAGE>
(collectively, the "Purchaser Indemnified Parties") from and against any and all
liabilities, losses, damages, claims, costs and expenses, interest, awards,
judgments and penalties (including, without limitation, reasonable attorneys'
fees and expenses) actually suffered or incurred by any of the Purchaser
Indemnified Parties (hereinafter, a "Purchaser Loss") arising out of or
resulting from any of the following:
(a) the breach by the Seller of any representation or warranty
contained herein or in any document delivered hereunder at the Closing (except
to the extent such breach has been caused by the Purchaser, as manager, in its
management of the Business);
(b) the breach by the Seller of any covenant or agreement contained
herein or in any document delivered hereunder at the Closing (except to the
extent such breach has been caused by the Purchaser, as manager, in its
management of the Business); or
(c) the failure of the Seller to pay or otherwise discharge any
liability or obligation incurred by it in connection with the Contracts or the
Business prior to the Closing Date (except to the extent such failure has been
caused by the Purchaser, as manager, in its management of the Business).
Section 7.2 Indemnification by the Purchaser. Except as otherwise limited by
this Article VII, the Purchaser shall indemnify, defend and hold harmless the
Seller and its officers, directors, independent contractors, agents, successors
and assigns (the "Seller Indemnified Parties") from and against any and all
liabilities, losses, damages, claims, costs and expenses, interest, awards,
judgments and penalties (including, without limitation, reasonable legal costs
and expenses) actually suffered or incurred by any of the Seller Indemnified
Parties (hereinafter, a "Seller Loss") arising out of or resulting from any of
the following:
(a) the breach by any of the Purchaser, Medigroup and BCBSNJ of any
representation or warranty contained herein or in any document delivered
hereunder at the Closing;
(b) the breach by any of the Purchaser, Medigroup and BCBSNJ of any
covenant or agreement contained herein or in any document delivered hereunder at
the Closing; or
(c) the failure of any of the Purchaser, Medigroup and BCBSNJ to pay or
otherwise discharge any liability or obligation incurred by such party in
connection with the Contracts or the Business from and after the Closing Date
(except for the Excluded Liabilities).
Section 7.3 General Indemnification Provisions.
----------------------------------
(a) For the purposes of this Section, the term "Indemnitee" shall refer
to the Purchaser Indemnified Parties or the Seller Indemnified Parties, as
applicable, entitled, or claiming to be entitled, to be indemnified, pursuant to
the provisions of Section 7.1 or 7.2 hereof, as the case may be; the term
"Indemnitor" shall refer to the person or persons having the obligation to
indemnify pursuant
17
<PAGE>
to such provisions; and "Losses" shall refer to the "Seller Losses" or the
"Purchaser Losses," as the case may be.
(b) An Indemnitee shall give written notice (a "Notice of Claim") to
the Indemnitor within ten (10) business days after the Indemnitee has knowledge
of any claim (including a Third Party Claim, as defined below) that an
Indemnitee has determined has given or could give rise to a right of
indemnification under this Agreement. No failure to give such Notice of Claim
shall affect the indemnification obligations of the Indemnitor hereunder, except
to the extent Indemnitor can demonstrate such failure materially prejudiced
Indemnitor's ability to successfully defend the matter giving rise to the claim.
The Notice of Claim shall state the nature of the claim, the amount of the
Losses, if known, and the method of computation thereof, all with reasonable
particularity and containing a reference to the provisions of this Agreement in
respect of which such right of indemnification is claimed or arises.
(c) The obligations and liabilities of an Indemnitor under this Article
VII with respect to Losses arising from claims of any third party that are
subject to the indemnification provisions provided for in this Article VII
("Third Party Claims") shall be governed by and contingent upon the following
additional terms and conditions: the Indemnitee at the time it gives a Notice of
Claim to the Indemnitor of the Third Party Claim shall advise the Indemnitor
that it shall be permitted, at its option, to assume and control the defense of
such Third Party Claim at its expense and through counsel of its choice if it
gives prompt notice of its intention to do so to the Indemnitee and confirms
that the Third Party Claim is one with respect to which the Indemnitor is
obligated to indemnify. In the event the Indemnitor exercises its right to
undertake the defense against any such Third Party Claim as provided above, the
Indemnitee shall cooperate with the Indemnitor in such defense and make
available to the Indemnitor all witnesses, pertinent records, materials and
information in its possession or under its control relating thereto as is
reasonably required by the Indemnitor. Similarly, in the event the Indemnitee
is, directly or indirectly, conducting the defense against any such Third Party
Claim, the Indemnitor shall cooperate with the Indemnitee in such defense and
make available to it all such witnesses, records, materials and information in
its possession or under its control relating thereto as is reasonably required
by the Indemnitee. Except for the settlement of a Third Party Claim that
involves the payment of money only and for which the Indemnitee is totally
indemnified by the Indemnitor, no Third Party Claim may be settled by the
Indemnitor without the written consent of the Indemnitee, which consent shall
not be unreasonably withheld. Similarly, no Third Party Claim may be settled by
the Indemnitee without the written consent of the Indemnitor, which consent
shall not be unreasonably withheld.
Section 7.4 Limit on Indemnification. The aggregate amount of all Purchaser
Losses subject to indemnification under this Article VII shall not exceed the
portion of the Purchase Price described in Section 1.5(A) above, subject to any
adjustment pursuant to Section 1.6 hereof.
18
<PAGE>
ARTICLE 8.
TERMINATION
Section 8.1 Termination of Agreement.
------------------------
This Agreement may be terminated at any time prior to the Closing:
(a) by written consent of the Purchaser and the Seller;
(b) subject to Section 4.4 hereof, by the Seller, if it becomes clear
that there is a condition precedent to Closing set forth in Article VI hereof
that cannot be satisfied;
(c) subject to Section 4.4 hereof, by the Purchaser, if it becomes
clear that there is a condition precedent to Closing set forth in Article V
hereof that cannot be satisfied;
(d) by the Seller, if a default by the Purchaser, as manager, occurs
under the Management Agreement, and in the event of such termination by the
Seller under this Section 8.1(d), Mellon shall disburse the entire Deposit and
all interest thereon to the Seller;
(e) by the Purchaser, if a default by the Seller occurs under the
Management Agreement, and in the event of such termination by the Purchaser
under this Section 8.1(e), Mellon shall disburse the entire Deposit and all
interest thereon to the Purchaser;
(f) by the Purchaser, upon written notice, if twelve (12) or more
months have elapsed since the date of this Agreement and the shareholders of the
Seller have not approved this Agreement prior to said notice; and in the event
of such termination by the Purchaser under this Section 8.1(f), Mellon shall
disburse $250,000 of the Deposit to the Purchaser and the remainder of the
Deposit and all interest thereon to the Seller;
(g) by the Purchaser, upon ninety (90) days advance written notice, if
twelve (12) or more months have elapsed since the date of this Agreement and the
shareholders of the Seller have approved this Agreement prior to said notice but
the Regulatory Agencies' approvals have not yet been secured; provided, however,
the Purchaser and the Seller shall utilize best efforts to secure said
Regulatory Agencies' approvals during the ninety (90) day-period between the
Purchaser notice and the effective date of termination hereunder. If this
Agreement is terminated under this Section 8.1(g), Mellon shall disburse the
entire Deposit and all interest thereon to the Seller; and
(h) by the Seller, upon written notice, if twelve (12) months or more
have elapsed since the date of this Agreement; and in the event of such
termination by the Seller under this Section 8.1(h), Mellon shall disburse the
entire Deposit and all interest thereon to the Purchaser.
19
<PAGE>
Section 8.2 Procedure and Effect of Termination. In the event of termination of
this Agreement by any party permitted to terminate this Agreement pursuant to
Section 8.1 hereof, written notice thereof shall forthwith be given to the other
parties hereto specifying the provision hereof pursuant to which such
termination is made, and this Agreement shall forthwith become void and of no
further force and effect, and there shall be no liability on the part of the
parties hereto (or their respective officers, directors or affiliates), except
as set forth in Sections 1.3, 4.2, 9.1 and 9.10 hereof and except that nothing
herein shall relieve either party from liability for any willful breach hereof.
ARTICLE 9.
MISCELLANEOUS
Section 9.1 Expenses; Taxes. All costs and expenses, including, without
limitation, fees and disbursements of counsel, financial advisors and
accountants, incurred in connection with this Agreement, the Management
Agreement and the Transaction shall be paid by the party incurring such costs
and expenses, whether or not the Closing shall have occurred. The Purchaser, on
the date of Closing, or, if due thereafter, promptly when due, shall pay all
excise, sales, value added, use, registration, stamp, transfer and similar
taxes, levies, charges, and fees incurred in connection with this Agreement and
the Transaction (other than income taxes due and payable by the Seller).
Section 9.2 Consents. Whenever this Agreement requires a consent by or on behalf
of any party hereto, such consent shall be given in writing in a manner
consistent with the requirements for a waiver of compliance as set forth in
Section 9.3 below.
Section 9.3 Waiver. Except as otherwise provided in this Agreement, any failure
of the parties to comply with any provision hereof may be waived by the party
entitled to the benefit thereof only by a written instrument signed by the party
granting such waiver, but such waiver or failure to insist upon strict
compliance with such provision shall not operate as a waiver of or estoppel with
respect to, any subsequent or other failure.
Section 9.4 Further Assurances. Each of the parties hereto agrees that, from and
after the Closing, upon the reasonable request of any other party hereto and
without further consideration, such party will execute and deliver to such other
party such documents and further assurances and will take such other actions
(without cost to such party) as such other party may reasonably request in order
to carry out the purpose and intention of this Agreement.
Section 9.5 Entire Agreement. This Agreement, the Exhibits and the Schedules and
the other writings referred to herein or delivered pursuant hereto that form a
part hereof contain the entire understanding of the parties with respect to the
subject matter hereof. This Agreement supersedes all prior agreements.
20
<PAGE>
Section 9.6 Amendment. This Agreement may be amended, modified, or superseded
only by an instrument signed by each of the parties hereto or, in the case of a
waiver, by or on behalf of the party waiving compliance.
Section 9.7 Headings. The Article and Section headings contained in this
Agreement are for reference purposes only and will not affect in any way the
meaning or interpretation of this Agreement.
Section 9.8 Notices. All notices, claims, certificates, requests, demands and
other communications hereunder will be in writing and will be deemed to have
been duly given if personally delivered or on the date of receipt indicated on
the return receipt if delivered or mailed (registered or certified mail, postage
prepaid, return receipt requested) as follows:
(a) If to the Seller:
Physician Healthcare Plan of New Jersey, Inc.
Princeton Pike Corporate Center
1009 Lenox Drive
Lawrenceville, New Jersey 08648
Attn: Chairman of the Board
with a copy to:
Ober, Kaler, Grimes & Shriver
A Professional Corporation
120 East Baltimore Street
Baltimore, Maryland 21202-1643
Attention: Carol M. McCarthy, Esquire
(b) If to the Purchaser:
Medigroup of New Jersey, Inc.
3 Penn Plaza East
Newark, New Jersey 07105-2200
Attn: Christy W. Bell
(c) If to Medigroup:
Medigroup, Inc.
3 Penn Plaza East
Newark, New Jersey 07105-2200
Attn: Christy W. Bell
21
<PAGE>
(d) If to BCBSNJ:
Blue Cross/Blue Shield of New Jersey, Inc.
3 Penn Plaza East
Newark, New Jersey 07105-2200
Attn: Robert J. Pures
or to such other address as the person to whom notice is to be given may have
previously furnished to the other in writing in the manner set forth above.
Section 9.9 Counterparts. This Agreement may be executed in any number of
counterparts, each of which when executed shall be deemed to be an original but
all of which, when taken together, shall constitute one and the same agreement.
Section 9.10 Public Announcements. The parties may issue press releases that are
approved by the Seller and BCBSNJ (acting on its own behalf and on behalf of the
Purchaser and Medigroup) upon the occurrence of the following events: the
approval by the Board of Directors of the Seller of this Agreement for referral
to the Seller's shareholders and upon the Closing. No other press releases,
announcements, marketing/promotional materials or other publicity regarding the
Transaction or this Agreement may be made, issued or distributed prior to the
Closing, without the express written consent of all the parties, including
consent as to content; provided, however, that nothing in this Agreement shall
prevent a party hereto from making any disclosure in connection with the
Transaction to such party's shareholders or to the extent required by law so
long as prior notice of such disclosure is given to the other party. The Seller
agrees that in any communications permitted by this Section the Purchaser may
describe the Transaction as "a purchase of the HMO and PPO operations of
Physician Healthcare Plan of New Jersey, the statewide HMO endorsed by the
Medical Society of the State of New Jersey." Any other description referencing
both the Seller and endorsement of any kind must be approved in form and
substance by the Seller.
Section 9.11 Construction. This Agreement and the other Seller Related Documents
and the other Purchaser Related Documents have been negotiated by the parties
and their respective legal counsel, and legal or equitable principles that might
require the construction of this Agreement or the other Seller Related Documents
or the other Purchaser Related Documents or any provision hereof or thereof
against the party drafting such agreements will not apply in any construction or
interpretation of this Agreement or the other Seller Related Documents or the
other Purchaser Related Documents.
Section 9.12 Recitals. The Recitals hereto are specifically incorporated herein
by reference and made a part of this Agreement as if they appeared in the body
hereof.
Section 9.13 Severability. Any provision of this Agreement that is invalid or
unenforceable shall be ineffective to the extent of such invalidity or
unenforceability and shall not affect in any way the remaining provisions
hereof.
22
<PAGE>
Section 9.14 Assignment. This Agreement and all of the provisions hereof shall
be binding upon and inure to the benefit of, the parties hereto and their
respective successors and permitted assigns, but neither this Agreement nor any
of the rights, interests or obligations herein shall be assigned by any party
hereto without the prior written consent of the other parties.
Section 9.15 Governing Law. This Agreement shall be governed by, and construed
and enforced in accordance with, the internal laws of the State of New Jersey
without regard to its provisions concerning conflicts or choice of law.
[SIGNATURES ON NEXT PAGE]
23
<PAGE>
IN WITNESS WHEREOF, this Agreement has been duly executed by the
parties as of the date first written above.
WITNESS/ATTEST: MEDIGROUP OF NEW JERSEY, INC.
By: /s/ Donna M. Celestini
----------------------------------
Donna M. Celestini
Executive Vice President
WITNESS/ATTEST: MEDIGROUP, INC.
By: /s/ Christy W. Bell
----------------------------------
Christy W. Bell
President and Chief Operating
Officer
WITNESS/ATTEST: BLUE CROSS AND BLUE SHIELD OF NEW
JERSEY, INC.
By: /s/ Christy W. Bell
----------------------------------
Christy W. Bell
Senior Vice President - Health
Industry Services
WITNESS/ATTEST: PHYSICIAN HEALTHCARE PLAN OF NEW
JERSEY, INC.
By: /s/ Joseph D. Billotti, M.D.
----------------------------------
Joseph D. Billoti, M.D.
Chairman of the Board
24
<PAGE>
EXHIBIT B
---------
OPINION OF SHATTUCK HAMMOND PARTNERS, INC.
September 11, 1997
Board of Directors
Physician Healthcare Plan of New Jersey, Inc.
1009 Lenox Drive, Bldg. 4
Lawrenceville, NJ 08648
Members of the Board of Directors:
Shattuck Hammond Partners Inc. ("Shattuck Hammond") understands that Physician
Healthcare Plan of New Jersey Inc. ("PHPNJ" or the "Company") has entered into
an Agreement dated as of June 26, 1997 (the "Purchase Agreement") between PHPNJ
and Medigroup of New Jersey, Inc. ("MEDIGROUP"), whereby Medigroup will acquire
substantially all of PHPNJ's group contracts and provider agreements (the
"Contracts") as specified in the Purchase Agreement (the "Purchase"). The cash
consideration to be paid by Medigroup to PHPNJ for Contracts pursuant to the
Purchase Agreement shall be equal to the greater of (a) $l ,000,000, or (b)
$300.00 per HMO member at c1osing (the "Cash Payment"); plus, a contingent
payment (the "Contingent Payment") equal to $10.00 for each eligible Health Care
Payers Coalition life to whom the services of the Medigroup network of providers
are available on the one year anniversary of the Closing Date ("the Closing Date
being defined as the date on which the transfer and assignment of the Contracts
is completed). After the Closing Date, PHPNJ shall surrender its HMO Certificate
of Authority to the State of New Jersey in accordance with applicable regulatory
requirements.
In Connection with Medigroup's acquisition of the Contracts, Medigroup and PHPNJ
have entered into, as of June 26, 1997, a Management Services Agreement (the
"Management Services Agreement") whereby Medigroup has agreed to provide
administrative and management services to PHPNJ as specified therein. Prior to
Medigroup providing services to PHPNJ under the Management Services Agreement,
certain management and administrative services were provided, directly or
indirectly, to PHPNJ by Medical Group Management, Inc. (the "Designated
Managers") pursuant to a Management Agreement dated as of September 1, 1994. The
management fee (the "Management Fee Accommodation") payable by PHPNJ to
Medigroup is $15.00 per member per month for each HMO member enrolled in PHPNJ
as of the first day of the month; provided, however, that (a) if PHPNJ's
shareholders disapprove the Purchase Agreement within six months of July 1,
1997, the Management Fee Accommodation shall be increased to $25.00 per member
per month ("PMPM"), effective either as of the date PHPNJ's shareholders
disapprove the Purchase Agreement or retroactive to the date 61 days from July
1, 1997, whichever occurs earlier, or (b) if PHPNJ's
<PAGE>
September 11, 1997
Page 2
shareholders have not voted on the Purchase Agreement by January 1, 1998, the
Management Fee Accommodation shall be increased to $25.00 PMPM, effective as of
the January 1998 payment. (Medigroup's acquisition of the Contracts from PHPNJ
pursuant to the Purchase Agreement for cash consideration equal to the sum of
the Cash Payment and the Contingent payment, together with Medigroup's
performance of certain management and administrative services pursuant to the
Management Services Agreement in consideration of PHPNJ's payment to Medigroup
of the Management Fee Accommodation are collectively referred to herein as the
("Transaction").
The Purchase Agreement also provides for representation on the board of
Medigroup, Inc., the parent of Medigroup, and various medical committees of
Medigroup and Blue Cross and Blue Shield of New Jersey, Inc. the parent of
Medigroup, Inc., by persons selected or nominated by PHPNJ. Such commitments are
non-financial in nature and therefore, we do not express any opinion on them.
Pursuant to an engagement letter dated July 30, 1997, you have asked for our
opinion, as investment bankers, as to the fairness, from a financial point of
view, as of June 26, 1997, of the Transaction to the holders of common stock of
PHPNJ. For the purpose of this opinion, we have: (i) reviewed certain publicly
available business and historical financial information relating to PHPNJ; (ii)
reviewed certain financial information and other data provided to us by PHPNJ
that is not publicly available relating to the business and prospects of the
Company; (iii) discussed the business, operations and prospects of PHPNJ with
the Designated Managers and the Board of Directors of the Company; (iv) reviewed
the Purchase Agreement, the Management Services Agreement and certain other
agreements; (v) reviewed publicly available financial and stock market data with
respect to publicly traded companies we considered relevant; (vi) reviewed
information regarding acquisitions of companies we considered relevant; and
(vii) conducted such others studies, analyses, investigations and inquiries, and
considered such other information as we deemed relevant.
In rendering our opinion, we have assumed and relied upon the accuracy and
completeness of all information supplied or otherwise made available to us by
PHPNJ or obtained by us from other sources, and we have relied upon the
assurances of PHPNJ and its Designated Managers that they are unaware of any
information or facts that would make the information provided to us incomplete
or misleading. We have assumed that the financial statements of PHPNJ present
fairly the financial position of the Company and that retained liabilities have
been adequately provided for. We have not independently verified any such
information, nor undertaken an independent appraisal of the asset or liabilities
(contingent or otherwise) of PHPNJ, nor been furnished with any such appraisal.
In addition, we have assumed that the Purchase will be consummated as provided
in the Purchase Agreement by December 31,1997, that the Management Services
Agreement took effect on July 1, 1997, and the Medigroup provides administrative
and management services to PHPNJ consistent with the terms of the Management
Services Agreement.
<PAGE>
September 11, 1997
Page 3
Our opinion is necessarily based upon market, economic and other conditions that
existed and could be evaluated as of June 26, 1997, and on information relevant
to expressing an opinion as to the fairness of the transaction as of June 26,
1997 which was available to us as of the date hereof. We disclaim any
undertaking or obligation to advise any person of any change in any fact or
matter affecting the opinion expressed herein which may come or be brought to
our attention after the date hereof. We note that PHPNJ does not prepare
financial forecasts and therefore did not provide any estimates of future
performance for our consideration or inclusion in our analyses. No other
limitations were imposed upon us by PHPNJ with respect to the investigations to
be made or procedures to be followed by us in rendering our opinion.
As part of its investment banking business, Shattuck Hammond Partners Inc. is
continually engaged in the valuation of businesses and their securities in
connection with mergers and acquisitions, negotiated underwritings, secondary
distributions of securities, private placements and other purposes. We have
acted as financial advisor to PHPNJ in connection with the transactions
described in this letter; were authorized by the Company to approach, and hold
discussion with, third parties to solicit indications of interest in a possible
acquisition of, investment in, or partnership with PHPNJ; have received a
retainer fee; and will receive additional fees for our services which are
contingent upon the consummation of the Purchase. We also will receive a fee
upon delivery of this opinion.
The opinion expressed herein does not constitute a recommendation as to any
action the Board of Directors or any stockholder of PHPNJ should take in
connection with the Transaction, or any part thereof, and our opinion is not
intended to be and does not constitute a recommendation as to how a stockholder
of PHPNJ should vote on the proposed Transaction or any part thereof. Further,
we express no opinion herein as to the structure, term or effect of any other
aspect of the Transaction, including, without limitation, the tax consequences
thereof.
It is understood that this letter is for the information of the Board of
Directors of PHPNJ in connection with its evaluation of the fairness, from a
financial point of view of the Transaction to the holders of common stock of
PHPNJ. Without limiting the foregoing, in rendering this opinion, we have not
been engaged to act as an agent or fiduciary for PHPNJ's common stockholders or
any other third party. This opinion may not be published, summarized, excerpted
from, or otherwise referred to nor shall any public reference to Shattuck
Hammond be made, without our prior written consent; provided, however, that this
opinion letter may be included in its entirety in. the Proxy statement of PHPNJ
relating to the Transaction.
Based upon and subject to the foregoing, it is our opinion as investment bankers
that as of June 26, l997 the Transaction is fair to the holders of PHPNJ common
stock from a financial point of view.
Very truly yours,
/s/ Shattuck Hammond Partners Inc.
- ----------------------------------------
Shattuck Hammond Partners Inc.
<PAGE>
PRELIMINARY COPY
----------------
PROXY
PHYSICIAN HEALTHCARE PLAN OF NEW JERSEY, INC.
SPECIAL MEETING OF STOCKHOLDERS
The undersigned hereby appoints Joseph D. Billotti, Bessie Sullivan,
Nancy Mueller and Linda Korman, or any one of them as attorneys-in-fact, with
full power of substitution, to vote in the manner indicated herein, and with
discretionary authority as to any other matters that may properly come before
the meeting, all shares of common stock of Physician Healthcare Plan of New
Jersey, Inc. which the undersigned is entitled to vote at the Special Meeting of
Stockholders of Physician Healthcare Plan of New Jersey, Inc. to be held on
Thursday, October 30, 1997 at 7:00 p.m., local time, at the Brunswick Hilton, 3
Tower Center Boulevard, East Brunswick, New Jersey or any adjournment thereof.
THIS PROXY IS SOLICITED BY AND ON BEHALF OF THE BOARD OF DIRECTORS.
This proxy when properly executed will be voted in the manner directed
herein by the undersigned stockholder. If no direction is indicated, this proxy
will be voted FOR the proposal.
APPROVAL OF EXECUTION, DELIVERY AND PERFORMANCE BY THE COMPANY OF (1)
THE AGREEMENT DATED AS OF JUNE 26, 1997 BETWEEN THE COMPANY AND MEDIGROUP OF NEW
JERSEY, INC., AS SUCH AGREEMENT MAY BE AMENDED TO COMPLY WITH APPLICABLE
REGULATORY REQUIREMENTS, AND (2) OTHER INSTRUMENTS AND DOCUMENTS REQUIRED TO BE
EXECUTED AND DELIVERED BY THE COMPANY AS DESCRIBED IN THE AGREEMENT, AND THE
CONSUMMATION OF THE ASSIGNMENT AND TRANSFER OF CERTAIN OF THE COMPANY'S
CONTRACTS AS DESCRIBED IN SUCH AGREEMENT, ALL AS SET FORTH IN THE ACCOMPANYING
PROXY STATEMENT.
FOR_______ AGAINST________ ABSTAIN_______
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE FOREGOING PROPOSAL.
Please mark, sign and date, and return this proxy card promptly using the
enclosed envelope.
________________________________
[attach label here] Signature(s)
Date: ________________________
Please sign exactly as name appears on the above label. If shares are held by
joint tenants, both should sign. When signing as attorney, executor,
administrator, trustee or guardian, please give full title as such. If signing
on behalf of an entity, please sign in the name of the entity by an authorized
person.
NOT VALID UNLESS DATED AND SIGNED ABOVE
